Author Index:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Abar, F.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Abbou, S.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Abe, Y.
High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis –Single Institute Analysis of 35 Cases–
Abedin, S.
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Abela, E. M.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Abernathy, A.
Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation
Abernethy, A.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Abhyankar, S.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Abidi, M. H.
Evaluating the Effect of High Dose Chemotherapy and Autologous Bone Marrow Transplantation (ASCT) On Hypertension (HTN) in Multiple Myeloma (MM) Patients
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Abosoudah, I.
Treatment of High-Risk Pre-B Acute Lymphoblastic Leukemia in a Fanconi Anemia Patient with Reduced-Intensity Chemotherapy
Abou Mourad, Y.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Abounader, D.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Abraham, A.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
Abraham, J.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Abramovitz, L.
Primary Immune Deficiencies
Abramovitz, L.
Incorporating Treatment Into Life: A Retrospective Analysis of Clinical, Financial and Quality of Life Measures Following Hematopoietic Stem Cell Transplant in Patients Receiving Home Subcutaneous Immune Globulin
Adams, A.
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Adams, R.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Adel, N. G.
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Adjei, A. M.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Adler, F.
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Afessa, B.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Agarwal, R.
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Agha, M.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Agrawal, V.
Double Haploidentical Hematopoietic Stem Cell Transplantation Enhances Anti-Tumor Activity After Transplant
Aguirre-Fernandez, G. C. Jr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Ahmad, I.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Ahmed, N.
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Ahmed, R.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
Ahn, J. Y.
Evaluation of Pre-Transplant Risk Factors of Bacterial Bloodstream Infection (BSI) in Patients with Hematopoietic Stem Cell Transplantation (HSCT) and Comparison of BSI Between Allogenic and Autologous HSCT
Ai, W. Z.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Akashi, K.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Akhtari, M.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Akpek, G.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Akyildiz, M.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
Al Farsi, K.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Habsi, Y.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Harthy, Z.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Al Huneini, M.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Khabori, M.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Kindi, S.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Lawati, A.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Mahrizi, R.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Manthari, I. M.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Al Mugairi, A.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Al Riyami, A. Z.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Riyami, I.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Al Shukri, M.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al Zadjali, S.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Al-Kadhimi, Z.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Al-Khabori, M.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Alakel, N.
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Alam, N.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Alangaden, K.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Alarcon-Urdaneta, C.
Body Mass Index As an Indicator of Prognosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institution Experience
Alavi, S.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Albano, M. S.
Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products
Albano, M.
Establishing a Post-Hematopoietic Stem Cell Transplant Immunization Clinic: A Single Institution Experience
Albert, M.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Algarotti, A.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Alikhan, M.
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Alimoghaddam, K.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Aljitawi, O.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
Aljurf, M. D.
(WC) International Studies
Allen, B.
Chronic Gvhd-Associated Serositis and Pericarditis
Allen, C.
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Allen, J. L.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Allende, H.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
Alonso, M. H.
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
Alousi, A. M.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Latest Investigations in GVHD Prophylaxis
The Importance of Ancillary Studies
Changing Paradigms in GVHD
Alpdogan, O.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Double Haploidentical Hematopoietic Stem Cell Transplantation Enhances Anti-Tumor Activity After Transplant
Alsina, M.
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Alsuliman, A.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Altan-Bonnet, G.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Altuntas, F.
BEAM or ICE?
Alyea, E. P. III
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Reducing Inappropriate Testing Following NCCN and IDSA Guidelines in Autologous Stem Cell Transplant (SCT) Patients
A Retrospective Review Comparing Outcomes of Patients Receiving Reinduction Therapy On House Staff and PA Services
Acute Leukemia - Diagnosis and Treatment
Amarnath, S.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Ames, B.
Glutathione Redox Metabolomic Dysregulation Precedes TNF-α Elevation and Predicts Severity of Gvhd in Experimental Transplantation
Amigues, I.
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Aminasnafi, M.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Amoruso, D.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Amylon, M.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Anagnostopoulos, A.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Anandasabapathy, N.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Anasetti, C.
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
Regulatory T CELLS Specific for Minor Histocompatibility Antigens
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Anderlini, P.
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Anderson, J.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Anderson, J.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Anderson, K.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Anderson, S.
Implementing Novel Predictive Parameters in Apheresis
Andersson, B. S.
The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Andhavarapu, S.
Effect of Body Mass Index On the Mobilizing Efficacy of Plerixafor in Patients Undergoing Autologous Stem Cell Collection: A Retrospective Study
Andreadis, C.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Andreansky, M.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Can Intravesical Instillation of Recombinant Activated Factor VII (rFVIIa) and Aminocaproic Acid (AA) Stop Bleeding in Hemorrhagic Cystitis?
Andresen, S.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Andritsos, L. A.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Ang, S.
Capitalizing On Epitope Escape to Avoid T Cell Fratricide without Compromising Targeting of CD56+ Tumors
Anil, P.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Annett, G.
A Novel State Funded Program to Increase Cord Blood Collections for Public Banking
Ansell, S. M.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Antin, J.
Reducing Inappropriate Testing Following NCCN and IDSA Guidelines in Autologous Stem Cell Transplant (SCT) Patients
Antin, J. H.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Antony, J.
IL-15 Alone Supports in Vitro Generation of Polyclonal CTL From CD3/CD28 Co-Stimulated Expanded CB T Cells Against Leukemia Cells
Antunes, L.
The Cost of Pediatric Unrelated HSCT
Anurathapan, U.
Novel Reduced Toxicity Conditioning Regimen for Older Severe Thalassemia Patients: Sequential Immunoablative Concept
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
BI-Specific T CELL Therapy for Pancreatic Cancer
Apostolou, C.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Appelbaum, F. R.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
AML - Lessons from the Clinic
Closing Remarks
E. Donnall Thomas: From Cooperstown to Global
E. Donnall Thomas: From Cooperstown to Global
E. Donnall Thomas: From Cooperstown to Global
Apperley, J. F.
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Improving Research Collaborations to Move Forward
Improving Research Collaborations to Move Forward
Improving Research Collaborations to Move Forward
Arad-Cohen, N.
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
Arai, S.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Arat, M.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
Arcese, W.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Ardalan, N.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Ardura, M.
Immunogenecity of Early Post Transplant Vaccination in Children
Armand, P.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Armenian, S. H.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Armistead, P.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Armitage, J. O.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Armstrong, E.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Armstrong, S. A.
Pathways Controlling Leukemia Stem Cell Development
Molecular Development and Therapeutic Targeting of Leukemia Stem Cells
Arnason, J.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Arnold, D.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Arnold, R.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Arnold, S.
Allogeneic Stem Cell Transplant for Children with Sickle Cell Disease Reduces Healthcare Utilization
Arora, M.
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
BMT CTN 0801: Chronic GVHD Treatment
BMT CTN 0801: Chronic GVHD Treatment
Arrieta, A.
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Arring, N.
Communication: Stagtegies to Improve Nurse to Nurse Handoff and Nurse-Provider Communication
Fall Reduction: Strategies in Action
Arsene, C.
Evaluating the Effect of High Dose Chemotherapy and Autologous Bone Marrow Transplantation (ASCT) On Hypertension (HTN) in Multiple Myeloma (MM) Patients
Artherholt, S. B.
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Artherholt, S. B.
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Arzanian, M. T.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Asano-Mori, Y.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Ashouri, N.
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Ashton, L. J.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Askar, M.
Human Di-Chimeric Cells a New Approach for Tolerance Inducing Protocols in Transplantation: A Preliminary Study
Askenazi, D.
Acute Kidney Injury (AKI) in Pediatric Hematopoietic Stem Cell Transplant Patients Predicts Day 100 Mortality
Assanelli, A.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Asvat, Y.
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Atenafu, E.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Atsuta, Y.
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
(WC) International Studies
Attar, E. C.
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Aulitzky, W. E.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Aung, F.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Avigan, D.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Avigdor, A.
Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients with Chemo-Sensitive Disease and with Treosulfan-Based Conditioning
Avila, D.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Avivi, I.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Awan, F. T.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight
Awasthi,
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Ayala, E.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
Ayas, M.
Treatment of High-Risk Pre-B Acute Lymphoblastic Leukemia in a Fanconi Anemia Patient with Reduced-Intensity Chemotherapy
(WC) Non-Malignant Marrow Disorders
Ayash, L. J.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Ayello, J.
Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Ayer, G.
Incorporating Treatment Into Life: A Retrospective Analysis of Clinical, Financial and Quality of Life Measures Following Hematopoietic Stem Cell Transplant in Patients Receiving Home Subcutaneous Immune Globulin
Azarnoush, S.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Aziz, M.
Evaluation of Post-Transplant Iron Chelation Therapy in Allogeneic Hematopoietic Stem Cell Transplant

B

Bach, D.
Clinical Features of Acute Cutaneous Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Bachanova, V.
Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD)
Bachier, C.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome
Sub-Therapeutic Levels of ORAL Tacrolimus Prophylaxis PRIOR to Allogeneic STEM CELL Transplant Do NOT Predict the Incidence of Chronic GRAFT Versus HOST Disease
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Baden, L.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Bader, P.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Bahlis, N.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Bailey, C. P.
Double Haploidentical Hematopoietic Stem Cell Transplantation Enhances Anti-Tumor Activity After Transplant
Bailey, S. D.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Bailey-Olson, M.
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Baird, K.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Bajgain, P.
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
Bajwa, R.
Vitamin D Status and Its Correlation with Bone Mineral Density in Long Term Survivors After Childhood Hematopoietic Stem Cell Transplantation
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Immunogenecity of Early Post Transplant Vaccination in Children
Baker, A.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Baker, K. S.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Balasetti, V. K.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Baldus, C. D.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Balduzzi, A.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Baliakas, P.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Balkhair, A.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Balkin, E.
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Ball, K.
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Ball, L.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Ballen, K.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Balls, J.
Plasma Cell CD20 Expression: Primary Aberrant Expression or Receptor up-Regulation
The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Leukocytosis Post Engraftment Is Associated with Increased Mortality Among Adult Allogeneic Hematopoietic Cell Transplant (HCT) Reciepients
Balshuesemann, D.
Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate
Bambace, N. M.
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Bandres, E.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Barata-Bardiella, A.
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Barba, P.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
Barber, K.
Standardizing Education and Competencies Across A Network
Barbosa, M. C.
Evaluation of Antioxidant Enzyme Levels of Glutathione Peroxidase in Patients Undergoing A Autologous Hematopoietic STEM CELL
Barilec, E.
Investigation of Community Respiratory Viruses in Hematopoietic Stem Cell Transplant Patients and Household Member Characteristics
Barker, J. N.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Vaccine Responses Following Unrelated Double Cord Blood Transplantation (CBT)
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Cord Blood Transplantation in 2013
New Approaches in Alternative Donor Transplantation
Barnes, J.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Barnes, S. M.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Barnes, T. H.
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Baron, F.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Oral Abstracts - Session F - Supportive Care & Autoimmune Transplants
Barone, J.
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Barowski, K.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
BMT CTN 1101: Haplo vs. Double Cord
BMT CTN 1101: Haplo vs. Double Cord
Transplant Center and BMT CTN DCC Perspectives on Randomized Trial Protocol Set-Up: 1101 Case Study
Barrett, A. J.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Leukemia Specific T Cells to Prevent or Treat Relapse
Future of Hematopoietic Stem Cell Transplant
Relapse
Future of Hematopoietic Stem Cell Transplant
Myeloablative, Reduced Intensity or Non-Myeloablative Conditioning Regimen
Barros, D. P.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Timely Capture of Relevant Data for Cibmtr
The Cost of Pediatric Unrelated HSCT
Barros, J. C. A.
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Bartoo, G.
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Baruchel, A.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Bascug, G.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Bashey, A.
Maintenance Hypomethylating Therapy Post Allogeneic Stem Cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous Leukemia or Non Responsive Myelodysplastic Syndrome
Bashir, Q.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Basirpanah, S.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Basquiera, A. L.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Bassett, R. Jr.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Basso, A. C.
Invasive Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results From a Single Center Retrospective Analysis
Basu, S.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Batchelor, T.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Bathurst, J.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Batra, S.
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Batsis, I.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Battaglini, C.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Battiwalla, M.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Baxter-Lowe, L. A.
Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of Agvhd
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies
Bayer, R. L.
Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation
A Single Institution's Experience Utilizing Augmented CBV for Patients with Relapsed Diffuse Large Cell Lymphoma Undergoing Autologous Stem Cell Transplantation
Bayliss, C. L.
The Reason Behind Two Ears and One Mouth: Listening More Than Talking At End of Life
Beard, B.
Ocular Chronic Gvhd: Increasing Opportunities for Impact and Awareness
Beardslee, C.
Tips to Prevent Form 2802, Lost to Follow-up
Beato, F.
Regulatory T CELLS Specific for Minor Histocompatibility Antigens
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Becker, P. S.
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Bednarski, J. J. II
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Beechuk, R.
Vitamin D Supplementation Decreases Grade 3-4 Acute Gvhd in Allogeneic Transplants with Normal Baseline Levels
Beethe, P.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Beguin, Y.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Behfar, M.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Bejanyan, N.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Bekkem, A.
Retrospective Analysis of Intravenous DMSO Toxicity in Transplant Patients
Beligaswatte, A.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Belle, L.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Bellile, E. L.
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Bellio, L.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Bellman, D.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Bello, C.
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
Beloki, L.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Belotti, D.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Bence-Bruckler, I.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Bendix, B. J.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Benjamin, J.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Bennett, C.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Benson, D. M.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Berdel, W. E.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Bergkvist, K.
Fifteen Years' Experience of Home Care During the Pancytopenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation
Berka, N.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Berkowitz, E. M.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Bernard, L.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Bernardi, M.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Berro, M.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Berteotti, G.
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Anti-Thymocyte Globulin At 6mg/Kg, Not 4.5mg/Kg, Protects From Severe Lethal Graft-Versus-Host Disease
Bertolazzi, K. O.
Incorporating Treatment Into Life: A Retrospective Analysis of Clinical, Financial and Quality of Life Measures Following Hematopoietic Stem Cell Transplant in Patients Receiving Home Subcutaneous Immune Globulin
Bertrand, Y.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Betcher, J.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Beumer, J. H.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Bevans, M.
Loneliness in Transplant Caregivers: Exploration of Related Factors
Bhatia, M.
Allogeneic Stem Cell Transplant for Children with Sickle Cell Disease Reduces Healthcare Utilization
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Bhatia, S.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Bhatt, A. S.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Bhattacharya, S.
Microbiology in Patients Undergoing Stem Cell Transplantation in the First Year of a Tertiary Care Comprehensive Cancer Centre From India
Bhave, S. J.
Microbiology in Patients Undergoing Stem Cell Transplantation in the First Year of a Tertiary Care Comprehensive Cancer Centre From India
Biagi, E.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Bibart, M. J.
Utilizing QI Tools to Decrease Line Contaminiations
Bierings, M.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Bierman, P. J.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Billups, R.
Process Determination of Information Technology System to Support BMT Program Operations
Improving Revenue Cycle for BMT: A Collaborative Network Approach
Billups, R.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Standardizing Education and Competencies Across A Network
Binder-Scholl, G.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Bingman, A.
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Binod, D.
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Binsfeld, M.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Biondi, A.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Bisharat, L.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Bishop, J.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
Allogeneic Stem Cell Transplant for Children with Sickle Cell Disease Reduces Healthcare Utilization
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Bishop, M. R.
(WC) Solid Tumors
Bitan, M.
Peri-Transplant Toxicity for Pediatric Patients with High-Risk Medulloblastoma Undergoing Tandem Autologous Hematopoietic Cell Transplantation
Bittencourt, H.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Blackburn, R.
Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Managing Hemorrhagic Cystitis in BMT Patients Using Continuous Bladder Irrigation
Individualized Care Planning Process
Blacklock-Schuver, B. A.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Blaise, D.
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Blake, A.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Blaschke, J.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Blatt, J.
Autologous Hematopoietic Cell Transplantation Can Prolong Life in High-Risk Neuroblastoma Patients in Partial Remission
Blazar, B. R.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Bleakley, M.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Bleau, S.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Bleesing, J.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Blinova, E.
Best Practices: Transitions of Care
Bloomfield, C. D.
Clinical Implications of Mutations in AML: Who Would Be Considered Candidates for Transplant?
Bloor, A.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Blum, E.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Blum, W.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Blyth, E.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
Bociek, R. G.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Boeckh, M. J.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis
How I Treat Resistant CMV
Viral Infections
(WC) Infection and Immune Reconstitution
Boelens, J. J.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Adenovirus PCR-Positivity in Stool Precedes Intestinal GRAFT Versus HOST Disease After Allogeneic Hematopoietic STEM CELL Transplantation
Predictors of Outcome of Hurler Syndrome Patients After Successful Hematopoietic Stem Cell Transplantation
Bogaerts, A.
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
Boku, S.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Bolaños-Meade, J.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Initial Therapy for Acute GVHD: What Did We Learn from BMT CTN 0802?
Boles, E. E.
Immune Reconstitution & Vaccine Response After Pediatric Allo-HSCT
Bollard, C. M.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Engineering Immunotherapy from Cord Blood Grafts
Enhancing Immune Reconstitution - from Bench to Bedside
Welcome to the 2013 BMT Tandem Meetings
Bolwell, B.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Bonavita, A.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Bonfim, C.
Challenges to Future Growth: The Transplant Center Perspective - Central/South America
Bonini, M. C.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Bontant, T.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Boo, M.
How Much Is Enough? Ethical Consideration for the Depletion of Large Public Cord Blood Units (CBU)
Bookout, R.
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Bordignon, C.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Bornhäuser, M.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Borowitz, M. J.
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Boruchov, A.
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Bosch, F.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
Bost, D.
Platform Independent Multiplex qPCR Research Assay for Chimerism Analysis
Identification and Typing of Killer-Cell Immunoglobulin-Like Receptors (KIRs) Using Quantitative PCR Assay Reagents for Research
Bost, D. A.
Research Qpcr Method for Engraftment Monitoring: A 6-Year Review of Proficiency Testing Results
Bouabdallah, R.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Boulad, F.
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Gene Therapy for Hemoglobinopathies
Bourgouin, P.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Boussiotis, V. A.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Bouzas, L. F. S.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Bowen, J. D.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Bowman, W. B.
Alcohol Impregnated Caps: Are They Effective for Preventing Clabsi?
Boyd, C.
Improving Reliability of Immunosuppressant Sampling Techniques
Boyiadzis, M.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Boyington, A. R.
Investigation of Community Respiratory Viruses in Hematopoietic Stem Cell Transplant Patients and Household Member Characteristics
Boyle, D. A.
Compassion Fatigue
Boyle, N.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Bradley, A. M.
Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight
New Drug Update
Bradstock, K.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Braendstrup, P.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Brændstrup, P.
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Braga, W. M. T.
Th17-Related Gene Rorγt Overexpressed in Patients with Chronic Gvhd: New Insights for T-Cell Manipulation and Gvhd Control
Braun, T.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Brazauskas, R.
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Braziel, R.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Breault, E.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Bredeson, C.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Bredeson, C.
DCI vs. Boost
Breese, E.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Breese, M.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Brenner, M. K.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
BI-Specific T CELL Therapy for Pancreatic Cancer
Brethon, B.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Breton, G.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Brewster, D.
Incidence and Mechanism for Decreasing Central Catheter Contamination of Calcineurin Inhibitors in Stem Cell Transplant Patients Utilizing an Educational Intervention
Brezina, M.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Briggs, A.
Transplant: The Ultimate Team Sport. A Potential Answer to Workforce Challenges in Hematopoietic Stem Cell Transplant
Briquet, A.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Broadwater, G.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Broady, R.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Broglie, L.
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Bronson, R. T.
The MGH Miniature Swine As a Large Animal Model of HCT and Graft Versus Host Disease
Brown, B.
Same Sibling Marrow Following Cord Allogeneic Transplantation As Therapy for Second Relapse APL: A Pediatric Case Report
Brown, C.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Brown, J.
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Brown, S.
Transplant Center and BMT CTN DCC Perspectives on Randomized Trial Protocol Set-Up: 1101 Case Study
Brown, W.
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Browning, M.
Autologous Stem Cell Collection for the Treatment of Malignant Diseases in Pediatric Patients: The Use of the Power Hickman
Brundage, T. M.
Monitoring Changes in Serum Albumin (SA) Concentrations As an Early and Objective Indicator of Potential CMX001-Associated Gastrointestinal (GI) Adverse Drug Effects
Renal Safety of Broad Spectrum Antiviral CMX001 in the Prevention of CMV Infection Post- Allogeneic Hematopoietic Cell Transplantation (HCT)
Brüning, M.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Brunner, A. M.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Brunner, J.
Forms Revision: Lymphoma Changes
Forms Revision: Multiple Myeloma Changes
Brunstein, C. G.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
BMT CTN 1101: Haplo vs. Double Cord
BMT CTN 1101: Haplo vs. Double Cord
Oral Abstracts - Session G - Allogeneic Transplants
Bryant, A.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Bryant, S.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Buadi, F.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Buadi, F.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Bubalo, J.
Best Practices: Transitions of Care
Buchbinder, D.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Buckingham, L.
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Buckley, N.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Buckley, R.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Bucuvalas, J. C.
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
Budak-Alpdogan, T.
Double Haploidentical Hematopoietic Stem Cell Transplantation Enhances Anti-Tumor Activity After Transplant
Buia-Amport, S.
WHAT Tools ARE in Your Toolbox to Promote Change?
Buitrago, J. A.
Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Managing Hemorrhagic Cystitis in BMT Patients Using Continuous Bladder Irrigation
Bunch, J.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Bunjes, D. W.
(WC) Acute Leukemia
Bunner, P.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Bunworasate, U.
Risk Factors for Dry Eye After Hematopoietic Stem Cell Transplantation
Burkart, J.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Burnette, B. L.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Burns, L.
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
Physician Shortage - Systems Capacity Initiative
Q&A
Burroughs, L.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Burrows, G.
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
Bushnell, M.
Vaccine Responses Following Unrelated Double Cord Blood Transplantation (CBT)
Busik, J. V.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Butler-Wu, S.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Buus, S.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Byam, C.
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Byersdorfer, C. A.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Byrne, M.
Continuous Infusion Cyclophosphamide and Low Dose Total Body Irradiation (CICy/ldTBI) As a Conditioning Regimen for Tandem Autologous Transplant in Multiple Myeloma
Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Relapsed After Initial Autologous Hematopoietic Cell Transplantation

C

Cabral, C. M. V.
Th17-Related Gene Rorγt Overexpressed in Patients with Chronic Gvhd: New Insights for T-Cell Manipulation and Gvhd Control
Caers, J.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Cain, W.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Cairo, M. S.
Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of Agvhd
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Role of Allogeneic Stem Cell Transplantation in Recurrent or Refractory Hodgkin Lymphoma
(PEDS) Advances in Stem Cell Transplantation in Childhood and Adolescent Lymphoma
(WC) Cellular Therapy
Calkoen, F.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Campbell, A. P.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Campos, S.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Cano, P.
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Cantor, J.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Cantu-Rodriguez, O. Sr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Canty, K.
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Cao, K.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Capelli, C.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Carabasi, M.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Caram, M. V.
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Carl, L.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Carli, K.
Managing of Daily Improvement (MDI) Through Daily Huddles: Creating Culture and Engaged Problem Solving Nurse Coordinator Staff At City of Hope Department of Hematology & Hematopoietic Cell Transplant (HEM/HCT)
Carlson, C.
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Carlstrom, K.
Description of Adverse Drug Events Associated with High-Dose Undiluted Etoposide (VP-16) Among Hematopoietic Stem Cell Transplant Recipients
Carlton, V.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Carmazzi, Y.
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Caron, M. L.
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Carpenter, P. A.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
Treatment for Chronic GVHD
(WC) Pediatric Cancer
Carr, J.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Carrabba, M.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Carrum, G.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Carter, S. L.
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Carvalho, D.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Cases, M.
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Cash, M.
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Caskey, M.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Castagna, L.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Castillo, N.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
Castro, M. X.
Post-Transplant Cyclophosphamide Is Feasible and Reduces Acute GvHD in Pediatric UCB Transplantation
Castro-Malaspina, H.
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Cavé, H.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Ceberio, I.
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Cerny, J.
Autologous STEM CELL Transplant (ASCT) As an Effective POST-Remission Consolidation Strategy for Good Risk ACUTE Myeloid Leukemia (AML) Patients
Cessna, J.
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Chabannon, C.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Chadakhtzian, A.
Incidence and Mechanism for Decreasing Central Catheter Contamination of Calcineurin Inhibitors in Stem Cell Transplant Patients Utilizing an Educational Intervention
Chagnon, M.
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Chai, X.
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Chakrabarti, S.
Persistently High Gam Levels Are Associated with Nonrelapse Mortality in HCT Recipients Irrespective of Invasive Aspergillosis: A Prospective Cohort Study
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Second Haploidentical PBSC Transplantation From the Same Donor After Early Relapse without Gvhd in Patients with Acute Leukemia
Chakraborty, A.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Chakrapani, A.
Microbiology in Patients Undergoing Stem Cell Transplantation in the First Year of a Tertiary Care Comprehensive Cancer Centre From India
Champlin, R. E.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Challenges to Future Growth: The Transplant Center Perspective - North America
Reduced-Intensity Transplants for Lymphoma: Reduced-Intensity Versus Full Transplant
Reduced-Intensity Transplants for Lymphoma: Reduced-Intensity Versus Full Transplant
Challenges to Future Growth: The Transplant Center Perspective - North America
Challenges to Future Growth: The Transplant Center Perspective - North America
Chan, K. W.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Chan, R. C.
BI-Specific T CELL Therapy for Pancreatic Cancer
Chandra, S.
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Chandrakasan, S.
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
Chandy, M.
Microbiology in Patients Undergoing Stem Cell Transplantation in the First Year of a Tertiary Care Comprehensive Cancer Centre From India
Chaney, C.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Chang, L.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
Chang, Y. J.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Chansard, L.
Transitioning Nurse-to-Nurse Report to the Bedside
Chanswangphuwana, C.
Risk Factors for Dry Eye After Hematopoietic Stem Cell Transplantation
Chao, N. J.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Implications of T Cell / Tregs
Chaparro, M.
Autologous Hematopoietic Stem Cell Transplantation in A Single Pediatric Center
Chapman, L.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Chari, A.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Chatterjee, S.
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Second Haploidentical PBSC Transplantation From the Same Donor After Early Relapse without Gvhd in Patients with Acute Leukemia
Chaturvedi, V.
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Chaudhry, A.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Chaudhury, S.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Chaudhury, S.
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Chavez, J. C.
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Chawla, K.
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Cheerva, A.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Chell, J.
How is Your Transplant Program Preparing for the Future - HCT 2020
Chen, A.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Pediatric Patients with High Risk Hematologic Malignanices
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Chen, A. I.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Chen, B. J.
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
Chen, G. L.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Chen, H.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Chen, J.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Chen, M.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
Chen, N.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Chen, X.
IL-15 Alone Supports in Vitro Generation of Polyclonal CTL From CD3/CD28 Co-Stimulated Expanded CB T Cells Against Leukemia Cells
Chen, X.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Chen, Y. B.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Chen, Y. H.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Cheng, G. S.
Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
Cherni, K.
Decreasing Readmission Rates in Autologous Stem Cell Transplant Patient for Symptom Management
Cherry, M.
Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant
Chevallier, P.
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Chewning, J. H.
Acute Kidney Injury (AKI) in Pediatric Hematopoietic Stem Cell Transplant Patients Predicts Day 100 Mortality
Chhabra, S.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Chi, A.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Chiang, A. K. S.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Chiattone, R.
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Chieh, H.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Chien, J.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Chiffelle, R.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Childs, R.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Chima, R.
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Chin, A.
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Chinen, J.
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Chiuzan, C.
Immune Reconstitution & Vaccine Response After Pediatric Allo-HSCT
Cho, B. S.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Cho, S. G.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Choi, S. S.
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
Choi, S. M.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Choi, S.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
Choo, K.
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Transforming Change of Shift Handoff: Implementing Walking Rounds in Adult Bone Marrow Transplant
Chou, J.
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
Chow, E.
Effectiveness of an Algorithm-Based Approach to Filgrastim-Based Mobilization Using Predetermined Decision Points for the Inclusion of Plerixafor
Utilization of an Algorithm for Chemomobilization Including the Use of Plerixafor in Poor Mobilizers
Chow, K.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Christiano, A.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Christiansen, C. B.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Christianson, D.
What to Expect...When Expecting an Audit
Christie, J.
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Christner, S.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Chu, Y.
Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Chung, D.
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Chung, D.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Incidence and Kinetics of CMV Infection After T-Cell Depleted and Unmodified Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience At Memorial Sloan-Kettering Cancer Center
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Chung, H.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Chute, J.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Chwieseni, E.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Ciaurriz, M.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Ciceri, F.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Cinarsoy, M.
BEAM or ICE?
Cipolla, D.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Ciubotariu, R.
Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products
Ciurea, S. O.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
civriz Bozdag, S.
BEAM or ICE?
Clark, G. J.
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Clark, J. J.
Challenges Facing the Adolescent Young Adult (AYA) Oncology and Stem Cell Transplantation Population
Clark, W.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Clayton, J.
Efficacy of Low-Dose Acyclovir Prophylaxis Against Varicella Zoster Virus in Pediatric Hematopoietic Stem Cell Transplantation Patients
Climov, M.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
Cline, C.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Cliver, P.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Cloughessy, M.
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Cofnas, P.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
Coghill, J.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Cogley, K. M.
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Cohen, J. B.
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Cohen, M. Z.
Patients' Expression of Treatment Outcome Uncertainty and Risk Before, During and After Stem Cell Transplantation
Cohen, S.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Cole, K.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Colgan, J. P.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Colleoni, G. W. B.
Th17-Related Gene Rorγt Overexpressed in Patients with Chronic Gvhd: New Insights for T-Cell Manipulation and Gvhd Control
Collings, A.
Standardizing Education and Competencies Across A Network
Collins, M.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Collins, M.
CIBMTR IT Update
Electronic Data Exchange: Current and Future Capabilities
Collins, N. H.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Comparison of GRAFT Content and Outcomes in BONE Marrow and PBPC Grafts After T CELL Depletion by Three Different Methods
Collum, K.
Implementation of an Electronic Form for Hematopoietic Stem Cell Transplant Infusions Improves Documentation Compliance
Colt, L.
Training Resource Follow-Up
Colturato, V. A.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Comeau, T.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Comenzo, R.
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
Comis, L.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Confer, D. L.
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
WBMT Luncheon Symposium: The Legacy of E. Donnall Thomas: 1 Million Hematopoietic Stem Cell Transplants
(ADMIN) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
(PHARM) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
Choosing a Donor
Finding the "Right" Donor
Challenges to Future Growth: The Donor Registry Perspective
Challenges to Future Growth: The Donor Registry Perspective
Challenges to Future Growth: The Donor Registry Perspective
Connelly, B.
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Connelly, J. A.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Conrad, R.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Constantini, S.
Peri-Transplant Toxicity for Pediatric Patients with High-Risk Medulloblastoma Undergoing Tandem Autologous Hematopoietic Cell Transplantation
Cooke, K. R.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
(PEDS) Viewing Transplant Immunology through Today's Lens: New Models, New Imaging and New Insights
(WC) Regimen-Related Toxicity and Supportive Care
Cooper, L. J. N.
Capitalizing On Epitope Escape to Avoid T Cell Fratricide without Compromising Targeting of CD56+ Tumors
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Copass, P.
Building Resiliency in New Nurses
Copelan, E.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Copelan, E. A.
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Coppola, M.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Corbet, K.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Cornelison, A. M.
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Cornelissen, J.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Cornell, R. F.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Oral Abstracts - Session J - Late Effects/Quality of Life & Immune Reconstitution
Cornett, D.
Evaluation of Blood Pressure Medication Use Associated with Cyclosporine-Induced Hypertension in the Allogeneic Bone Marrow Transplant Population
Cornman, S.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Correa, M. E.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Corrigan, P.
Evaluation of Post-Transplant Iron Chelation Therapy in Allogeneic Hematopoietic Stem Cell Transplant
Cortellazzo, S.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Cortes, J.
(WC) Chronic Leukemia
Corti, C.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Costa, L. J.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Characterization of Cardiac Arrhythmias Post Allogeneic Transplant
Evaluation of Blood Pressure Medication Use Associated with Cyclosporine-Induced Hypertension in the Allogeneic Bone Marrow Transplant Population
Costello, D.
Communication: Stagtegies to Improve Nurse to Nurse Handoff and Nurse-Provider Communication
Fall Reduction: Strategies in Action
Cotliar, J.
Clinical Features of Acute Cutaneous Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Cottle-Delisle, C.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Coughlin, E.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Couriel, D. R.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Vitamin D Supplementation Decreases Grade 3-4 Acute Gvhd in Allogeneic Transplants with Normal Baseline Levels
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
Advances in the Management of GVHD
Courtney, C.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Couture, C.
Accurate Data Reporting
Couture, C.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Covington, D.
Effectiveness of an Algorithm-Based Approach to Filgrastim-Based Mobilization Using Predetermined Decision Points for the Inclusion of Plerixafor
Utilization of an Algorithm for Chemomobilization Including the Use of Plerixafor in Poor Mobilizers
Cowan, M. J.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Recovery of Lymphocyte Function May Predict Risk of Leukemic Relapse in Pediatric Patients Undergoing Allogeneic Stem Cell Transplant
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies
Cowen, E. W.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Cox, J.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Cox, T.
Standardizing Education and Competencies Across A Network
Coyle, D.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Cozzi, J.
Invasive Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results From a Single Center Retrospective Analysis
Craddock, J.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Craddock, J.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Craig, M.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Crepeau, R. L.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
Crocchiolo, R.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Cross, S.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Crossland, D.
Capitalizing On Epitope Escape to Avoid T Cell Fratricide without Compromising Targeting of CD56+ Tumors
Crown, D.
Implementing Novel Predictive Parameters in Apheresis
Cruz, N.
Neurocognitive Function in Pediatric Stem Cell Transplant Recipients Following Low Dose Single Fraction Total Body Radiation and Cyclophosphamide
Cuccovia, B. A.
WHAT Tools ARE in Your Toolbox to Promote Change?
Cuello, B.
Implementation of Fact Guidelines Improves Donor Screening
Cuijpers, M.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Cumpston, A.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Cunnigham, S.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Cuthrell, P.
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Opening Remarks
Cutler, C.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
BMT CTN 0402: Sirolimus for GVHD
BMT CTN 1102: MDS
BMT 101 Lecture for APPs
(WC) Graft-versus-Host Disease
Cuvelier, G.
Survival Improvements Following Omega-3 Polyunsaturated Fatty Acid Dietary Enrichment, Acetylsalicylic Acid, and Aspirin-Triggered Lipoxin Administration in a Lethal Mouse Model of Acute Graft-Versus-Host Disease
Cwykiel, J.
Human Di-Chimeric Cells a New Approach for Tolerance Inducing Protocols in Transplantation: A Preliminary Study

D

D'Agostino, R. Jr.
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
D'Auria, J. P.
Supporting Siblings Through the Allogeneic Hematopoietic Cell Transplant Process: The Perspectives of Minor and Young Adult Siblings of Successful Transplant Recipients
D`Amico, G.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Dadwal, S. S.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Dagis, A.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Dahi, P.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Dahl, G.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Dai, K.
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Dai, Y.
Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Relapsed After Initial Autologous Hematopoietic Cell Transplantation
Dalal, B. I.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Dalal, J.
Utilization and Outcome of Bone Marrow Transplantation in Children with Sickle Cell Disease: A Pediatric Health Information System Database Analysis
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Daley, J.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Dallas, M. H.
Elevated Gamma Delta T Cell Recovery Following Hematopoietic Stem Cell Transplantation Associated with Improved Long Term Overall Survival in Pediatric Patients with Acute Leukemia
Isolation, Expansion & Function of Cord Blood Natural Killer Cells
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Young Adult and Adolescent Patients: Care Issues for All Nurses
Dalle, J. H.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Daly, A.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Damodar, S.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Damon, L. E.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Damstetter, E.
Clinical Features of Acute Cutaneous Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Dander, E.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Dandoy, C.
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Secondary Hemophagocytic Lymphohistiocytosis (HLH) From a Brown Recluse Spider Bite
Daniels, K.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Danner-Koptik, K.
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Transition to Long-Term Follow-Up: Empowering Survivors!
Das Gupta, N.
NKG2D Ligands in Pediatric Cancer
Daum, C.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Development of a Consistent Approach to the Management Chemo/Radiation Induced Dermatitis in Children Undergoing Allogeneic Stem Cell Transplantation
David, J.
Transplant Center and BMT CTN DCC Perspectives on Randomized Trial Protocol Set-Up: 1101 Case Study
Davidson, J.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Davies, S. M.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Adherence to the Outpatient Oral Medication Regime in Adolescent HSCT Recipients
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Pediatric Acute Leukemia
Practice Variations
Davis, B.
Managing Skin and Wound Care On a BMT Unit
Davis, D. I.
Efficacy of Low-Dose Acyclovir Prophylaxis Against Varicella Zoster Virus in Pediatric Hematopoietic Stem Cell Transplantation Patients
Davis, E. L.
Upfront Calcineurin Inhibitor Dose Reduction of 40% in Pediatric Haematopoietic Stem Cell Transplant Does Not Result in Increased Graft Versus Host Disease in Patients Receiving Voriconazole Maintenance Therapy
Davis, L.
Individualized Care Planning Process
Davis, T.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Day, S.
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Dayangac, M.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
De Kesel Lofthus, A.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
de la Cruz, B.
Individualized Care Planning Process
De la Vega-Diaz, I.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
De Las Casas, C.
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
de Lavallade, H.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
de Lima, M.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Hypomethylating Agents Post HCT
Oral Abstracts - Session F - Supportive Care & Autoimmune Transplants
de Lima, M.
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Cord Blood Storage for ≥ 5 Years Does Not Impact Engraftment
de Oliveira, J. S. R.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Th17-Related Gene Rorγt Overexpressed in Patients with Chronic Gvhd: New Insights for T-Cell Manipulation and Gvhd Control
De Oliveira, S.
Same Sibling Marrow Following Cord Allogeneic Transplantation As Therapy for Second Relapse APL: A Pediatric Case Report
de Souza, C. V.
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Deal, A. M.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Dean, R. M.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Deane, T.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Deangelo, D.
A Retrospective Review Comparing Outcomes of Patients Receiving Reinduction Therapy On House Staff and PA Services
Deans, R.
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
DeCook, L.
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Deeg, H. J.
(WC) Non-Malignant Marrow Disorders
DeFilipp, Z.
Anti-Thymocyte Globulin At 6mg/Kg, Not 4.5mg/Kg, Protects From Severe Lethal Graft-Versus-Host Disease
Defor, T.
Hematopoietic Cell Transplantation for Acute Leukemia and Advanced Myelodysplastic Syndrome in Fanconi Anemia
Dehn, J.
Young Male Donors Provide the Best Chance of Meeting Requested Cell Dose for PBSC and Bone Marrow Transplantation
How Much Is Enough? Ethical Consideration for the Depletion of Large Public Cord Blood Units (CBU)
DeJarnette, S.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
del Canizo, C.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
Del Rio, C.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Dela Cruz, B.
Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Managing Hemorrhagic Cystitis in BMT Patients Using Continuous Bladder Irrigation
Delaney, C.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Delaney, C.
Higher Infused CD34+ Dose Positively Influence Platelet Recovery After Cord Blood Transplantation
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Cord Blood Graft Engineering: Current State of the Art
Cord Blood Graft Engineering
Delaunay, J.
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
DeLeon, M.
Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products
Delisle, J. S.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Dell, S.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Demiriz, I.
BEAM or ICE?
Demmel, K. M.
Sustaining the Gain: A Units Quest to Maintain Significant Catheter Associated Blood Stream Infection (CA-BSI) Rate Reductions
The Ticking Clock, Time to First Antibiotic in a Highly Complex Pediatric Bone Marrow Transplant Ambulatory Setting
Dennison, D.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Denzen, E.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
Substantial Variation in Medicaid Coverage for Hematopoietic Cell Transplantation
Deol, A.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Deola, S.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Deoliveira, D.
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
DeRemer, D.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight
Deren, S.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
DeSantes, K.
Diagnostic and Treatment Dilemmas From Statewide Newborn Screening for Severe Combined Immunodeficiency
Devine, H.
SIG Updates ASBMT / ONS
Hot Topics
Devine, S. M.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
(WC) Acute Leukemia
Devlin, S.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
The Management of Relapsed AML or MDS Following a T-Cell Depleted Allogeneic Stem Cell Transplant
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Dey, B. R.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
DeYoung, K. T.
Examining the Evidence for Frequency of Vital Sign Monitoring During Transfusion of Blood Products in the Stem Cell Transplant Patient Population
Dharmani, P.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
di Stasi, A.
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Dibb, J.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Dibb, W.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Diez Campelo, M.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
DiFronzo, N.
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Diggs, L.
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Dilley, K.
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Dinarello, C.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
Dingli, D.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Dinh, Y.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Diniz, M. P.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Timely Capture of Relevant Data for Cibmtr
Dioguardi, J.
Factors Impacting Family Decisions to Pursue Transplantation for Children with Sickle Cell Disease
Dioguardi, J. V.
Current Attitudes of Parents and Patients towards Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia
APP Research Subcommittee
DiPersio, J. F.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
(WC) Acute Leukemia
Dispenzieri, A.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Forms Revision: Multiple Myeloma Changes
(WC) Plasma Cell Disorders
Divine, C. L.
Staffing Models
Dobrila, N. L.
Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products
Dockery, J.
Alcohol Impregnated Caps: Are They Effective for Preventing Clabsi?
Dodd, T.
Networking for Quality: Benchmarking with Peers for Program Excellence
Managing Transitions from Paper to Computerized Systems
Dodds, D. A.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Domingues, F.
The Cost of Pediatric Unrelated HSCT
Dominguez, J. R.
The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan
Domm, J.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Donahue, L.
Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation
A Single Institution's Experience Utilizing Augmented CBV for Patients with Relapsed Diffuse Large Cell Lymphoma Undergoing Autologous Stem Cell Transplantation
Donnelly, M.
Therapeutic Relationship Education On a Pediatric Bone Marrow Transplant and Immunology Unit
Dörken, B.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Doro, M. P.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Doubrovina, E. S.
Epitopes of CMVpp65 Co-Presented by Multiple Allelic Variants of HLA Class-I Antigens: Implications for Adoptive Immunotherapy for CMV Using Third Party Donor –Derived CMV Specific CTLs
Douglas, D.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Douka, V.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Drago, S.
Apheresis in the ABMT Outpatient Setting
Drake, K.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Driscoll, J.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Drobyski, W.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Drummy, N.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Duane, C.
Therapeutic Relationship Education On a Pediatric Bone Marrow Transplant and Immunology Unit
Duarte, F.
Evaluation of Antioxidant Enzyme Levels of Glutathione Peroxidase in Patients Undergoing A Autologous Hematopoietic STEM CELL
Duarte, L.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Dubois, S.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Dudek, S.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Dueck, A.
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Duerst, R. E.
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Duggan, P. R.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Duke, F.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Duncan, C.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Transplanting Children with Hematologic Malignancy and Down Syndrome
(PEDS) Unique Pediatric HCT Populations
(WC) Late Effects and Quality of Life
Duncan, T.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Duong, A.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Duong, H.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Duquesne, F.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Duran-Struuck, R.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
The MGH Miniature Swine As a Large Animal Model of HCT and Graft Versus Host Disease
Duval, M.
Therapeutic Drug Monitoring (TDM) of Cyclosporine Using the Area Under the Curve in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Dvir, R.
Peri-Transplant Toxicity for Pediatric Patients with High-Risk Medulloblastoma Undergoing Tandem Autologous Hematopoietic Cell Transplantation
Dvorak, C. C.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Recovery of Lymphocyte Function May Predict Risk of Leukemic Relapse in Pediatric Patients Undergoing Allogeneic Stem Cell Transplant
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies

E

Eapen, M.
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Choice of Alternative Donors for Aplastic Anemia
Benefits of Peripheral Blood vs. Bone Marrow
Practice Variations
Earl, A.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Ebell, W.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Eby, C.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Eckert, C.
Transitioning Nurse-to-Nurse Report to the Bedside
Edelman, J.
Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Edwards, S.
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Efebera, Y.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Efron, B.
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Egeler, R. M.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Ehlert, K.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Ehninger, G.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Einsele, H.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
El-Bietar, J. A.
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
EL-Cheikh, J.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Elder, E.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Elder, P.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Elekes, A.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Elera, C.
Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation
Elhasid, R.
Peri-Transplant Toxicity for Pediatric Patients with High-Risk Medulloblastoma Undergoing Tandem Autologous Hematopoietic Cell Transplantation
Elison, K.
A Multidisciplinary Intervention Fosters Dissemination and RAPID Implementation of Evidence Based Medicine
Elledge, C.
Standardizing Education and Competencies Across A Network
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Ellison, C.
Survival Improvements Following Omega-3 Polyunsaturated Fatty Acid Dietary Enrichment, Acetylsalicylic Acid, and Aspirin-Triggered Lipoxin Administration in a Lethal Mouse Model of Acute Graft-Versus-Host Disease
Ellison, L.
Moving Mobilization Chemotherapy From the Inpatient to the Outpatient Setting
Elmacken, M.
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Elmer, E.
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Elsayed, Y.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Emerson, R. O.
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Emmert, A.
Implementing Novel Predictive Parameters in Apheresis
Staffing Models
Englesbe, M.
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Englund, J. A.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Eom, K. S.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Eriguchi, Y.
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Erkers, T.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Esiashvili, N.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Esselmann, J.
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Essl, M.
Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate
Estrella, J. M.
Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Managing Hemorrhagic Cystitis in BMT Patients Using Continuous Bladder Irrigation
Estupiñan, M.
Autologous Hematopoietic Stem Cell Transplantation in A Single Pediatric Center
Etienne, A.
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Eto, T.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Eto, Y.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Eulenstein, U.
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Evans, K.
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Evans, S.
Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight
Evens, A.
Autologous STEM CELL Transplant (ASCT) As an Effective POST-Remission Consolidation Strategy for Good Risk ACUTE Myeloid Leukemia (AML) Patients
Expose-Spencer, J.
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies

F

Faber, E. A.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Fackler, L. S.
A Comprehensive Review of Dfci's Adult HSCT Data
Fagundes, T. Jr.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Faham, M.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Fahd, M.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Fahmy, O. A. Sr.
Long-Term Follow up of SAA Patients Allografted with a Non-ATG-Based Conditioning Regimen, Using Pbscs As the Sole Source of Engraftment: A Single Center Experience of 53 Patients Above the Age of 20 Years
Faiman, B.
Multiple Myeloma
Faison, A. E.
Effectiveness of an Algorithm-Based Approach to Filgrastim-Based Mobilization Using Predetermined Decision Points for the Inclusion of Plerixafor
Utilization of an Algorithm for Chemomobilization Including the Use of Plerixafor in Poor Mobilizers
Falk, W.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Fan, G.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Fan, W.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Farhan, S.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
Faridi, R. M.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Farnia, S.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Substantial Variation in Medicaid Coverage for Hematopoietic Cell Transplantation
Improving Revenue Cycle for BMT: A Collaborative Network Approach
Farol, L. T.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Fasan, O.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Fauble, V.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Fauble, V.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Faulkner, L. B.
Hematopoietic Stem Cell Transplantation for Thalassemia: A Global Perspective
Fayad, P.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Fazal, S.
Anti-Thymocyte Globulin At 6mg/Kg, Not 4.5mg/Kg, Protects From Severe Lethal Graft-Versus-Host Disease
Fedoriw, G.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Fei, M.
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Fein, D.
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
Feinstein, L.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
Feliciano, N.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Felix, O. M. W. D. O.
Timely Capture of Relevant Data for Cibmtr
The Cost of Pediatric Unrelated HSCT
Fellowes, V.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Fenske, T.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Fernandes, J.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Fernandez, H.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Fernandez Vina, M. A.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Histocompatibility Criteria for Selection of Donors in Allogeneic Hematopoietic Stem Cell Transplantation
Fernandez-Vina, M.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
(WC) Immunobiology
Ferrante, R.
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Ferrara, J. L. M.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Ferraro, C.
Decreasing Readmission Rates in Autologous Stem Cell Transplant Patient for Symptom Management
Feustel, J.
Transforming Change of Shift Handoff: Implementing Walking Rounds in Adult Bone Marrow Transplant
Fidler, C. J.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Field, T.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Fieno, A. M.
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Figueroa, C.
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Filicko, J.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC)
Filipovich, A.
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Filipovich, A.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Finnerty, M.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Fischer, A.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Fischer, S. E.
Towards the Development of a Closed, Nanofiber-Based Culture System for Clinical Expansion of Cord Blood CD34+ Cells
Fisher, C. E.
The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis
Fisher, D. R.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Fitzgerald, J.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Fleischhauer, K.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Flesch, A.
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Flesch, L.
Sustaining the Gain: A Units Quest to Maintain Significant Catheter Associated Blood Stream Infection (CA-BSI) Rate Reductions
Therapeutic Relationship Education On a Pediatric Bone Marrow Transplant and Immunology Unit
The Ticking Clock, Time to First Antibiotic in a Highly Complex Pediatric Bone Marrow Transplant Ambulatory Setting
Fletcher, T.
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Flinn, I. W.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Flomenberg, N.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC)
Double Haploidentical Hematopoietic Stem Cell Transplantation Enhances Anti-Tumor Activity After Transplant
Florek, M.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Florez, I.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Flowers, C.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Flowers, M. E. D.
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
(WC) Graft-versus-Host Disease
Foley, S.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Folkert, J.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome
Fondaw, M.
Plasma Cell CD20 Expression: Primary Aberrant Expression or Receptor up-Regulation
The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Leukocytosis Post Engraftment Is Associated with Increased Mortality Among Adult Allogeneic Hematopoietic Cell Transplant (HCT) Reciepients
Fong, J.
Polymicrobial and Multiple Microbiologically Proven Infections in HSCT Recipients
Ford, R.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
SIG Updates ASBMT / ONS
Fore, M.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Forget, M. A.
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Forman, S. J.
Clofarabine and High-Dose Melphalan As Reduced Intensity Conditioning in Adults with High-Risk Leukemia/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
(ADMIN) Thursday Scientific Luncheon Symposium: The Impact of Reduced-Intensity Conditioning Regimens in Transplant Outcomes
Reduced-Intensity Transplants for Leukemia: Reduced-Intensity Versus Full Transplant
Reduced-Intensity Transplants for Leukemia: Reduced-Intensity Versus Full Transplant
BMT Tandem Luncheon Symposium: The Impact of Reduced-Intensity Conditioning Regimens in Transplant Outcomes
Fowler, D.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
(WC) Graft Sources and Manipulation
Fox, P. S.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Frame, D.
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Vitamin D Supplementation Decreases Grade 3-4 Acute Gvhd in Allogeneic Transplants with Normal Baseline Levels
Franck, A.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Frayo, S. L.
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Freeman, S.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Freytes, C. O.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Friend, E.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Frires, R.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Frith, J.
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Fromm, P. D.
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Fry, T.
Donor Advocacy (Peds and Adult)
Fu, H. X.
Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Fuchs, E.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Pediatric Patients with High Risk Hematologic Malignanices
Fujii, N.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Fujioka, T.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Fujiwara, H.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Fukuda, T.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Fukuda, T.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Fung, H. C.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Funke, V.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Funke, V. A. M. Sr.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Furer, R.
Peri-Transplant Toxicity for Pediatric Patients with High-Risk Medulloblastoma Undergoing Tandem Autologous Hematopoietic Cell Transplantation
Fürst, D.
Missing KIR-Ligands in Single Mismatched Unrelated Hematopoietic Stem Cell Transplantation
Furst, S.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Furtado, V. F. Jr.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Furth, E. E.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Furth, S.
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)

G

Gaballa, S.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Gaensler, K. M.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Gaffney, J. R.
Delivering Seamless Education throughout a Hematopoietic Progenitor Cell Transplant (HPCT) to the Patient and Caregiver
Gaipa, G.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Gajewski, J.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Galal, A.
Autologous Transplantation As Consolidation Therapy for Primary and Secondary CNS Lymphoma- A Single Center Experience
Galambrun, C.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Galamidi-Cohen, E.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Galardy, P.
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Gallez-hawkins, G.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Galo-Hooker, E.
In Pursuit of the Graft Versus Myeloma Effect: A Single Institution Experience
Galvin, J. P.
Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Gamper, C.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Pediatric Patients with High Risk Hematologic Malignanices
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Ganapule, A.
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
Gandemer, V.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Gandhi, N.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Ganguly, S. S.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Ganguly, S.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Ganguly, S.
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Garavaglia, K.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Garcia, A.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Garcia, C. Jr.
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Garcia, J.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Gardner, K.
Welcome / Staff Introductions
Garee, A.
Impact of Specialty Nursing Model On Pediatric Bone Marrow Transplant Patient Outcomes
Vitamin D Status and Its Correlation with Bone Mineral Density in Long Term Survivors After Childhood Hematopoietic Stem Cell Transplantation
Garfall, A. L.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Garfin, P. M.
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Garvin, J.
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Garzon, R.
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Gascoyne, R. D.
Biology of Diffuse Large B Cell Lymphoma
Gasparetto, C.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Gastineau, D.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Gattillo, S.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Gauthier, S. D.
The Restorative Effect of Flt3-Ligand and IL-7 On CD4+ T Cell Homeostatic Proliferation During Graft-Versus-Host Disease
Gaylor, C.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Gea-Banacloche, J.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
(WC) Infection and Immune Reconstitution
Geary, J.
Implementing Novel Predictive Parameters in Apheresis
Geddes, M.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Gee, A. P.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Gefen, A.
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
Gehris, R. P.
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Gelabert, M. A.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
George, B.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
George, D.
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
George, Y.
Commitment to an Intergrated Health Model
Georges, G.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Georgiadou, E.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Gerber, S.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Gerdemann, U.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Gerds, T.
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Gernsheimer, T.
Higher Infused CD34+ Dose Positively Influence Platelet Recovery After Cord Blood Transplantation
Gersten, I.
BMT CTN 1205: Easy to Read Informed Consent
BMT CTN 0801: Chronic GVHD Treatment
Gertz, M.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Getrajdman, G. I.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Gevers, D.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Geyer, M.
Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of Agvhd
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Geyer, S.
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Gharib, A.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Ghavamzadeh, A.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Giallombardo, N.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Gibbons, J.
Transitioning Nurse-to-Nurse Report to the Bedside
Gibson, C.
Cancer Registrars Evolving in Bone Marrow Transplant Data Management
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Gibson, L. F.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Gilbreth, C.
Standardizing Education and Competencies Across A Network
Gilleece, M. H.
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Giller, R.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Gillio, A. P.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Gilman, A.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Ginani, V. C.
The Cost of Pediatric Unrelated HSCT
Giralt, S. A.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
The Management of Relapsed AML or MDS Following a T-Cell Depleted Allogeneic Stem Cell Transplant
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
PI and Site Coordinator Protocol Adherence Panel
Giver, C.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Glejf, J.
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Glezerman, I.
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Glick, G. D.
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Glode, A. E.
Characterization of Cardiac Arrhythmias Post Allogeneic Transplant
Evaluation of Blood Pressure Medication Use Associated with Cyclosporine-Induced Hypertension in the Allogeneic Bone Marrow Transplant Population
Glotzbecker, B.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Reducing Inappropriate Testing Following NCCN and IDSA Guidelines in Autologous Stem Cell Transplant (SCT) Patients
A Retrospective Review Comparing Outcomes of Patients Receiving Reinduction Therapy On House Staff and PA Services
Oral Abstracts - Session M - Lymphoma/Multiple Myeloma
Gluckman, E.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Gnjatic, S.
CT7/MAGE-C1 Expression and Immune Responses Following Allogeneic Transplant for Multiple Myeloma
Goebel, J.
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Goebel, W. S.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Gokbuget, N.
How do BiTE Antibodies fit into the Strategy for Effective Management of Adult ALL?
Golay, J.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Goldberg, J.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Goldman, F.
Acute Kidney Injury (AKI) in Pediatric Hematopoietic Stem Cell Transplant Patients Predicts Day 100 Mortality
Goldman, J. M.
ASBMT Lifetime Achievement Award
How to Get Your Paper Published
Goldstein, S. C.
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
(WC) Donor Health and Safety
Goldstein, S. C.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Gomez, A.
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Gomez-Almaguer, D. Sr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Gonçalves, R. P.
Evaluation of Antioxidant Enzyme Levels of Glutathione Peroxidase in Patients Undergoing A Autologous Hematopoietic STEM CELL
Gonzales, A. M.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Gonzalez, B.
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Gonzalez, L.
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Gonzalez-Llano, O. Sr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Goodell, S.
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Goodridge, M.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Gooley, T.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Gopal, A. K.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Gordon, K.
Bridging the Silos: Utilizing the Lean Model Rapid Improvement Event to Improve the Mobilization Process
Gordon, L. I.
Standardizing Standard Operating Procedures' (SOP) Manual to Benchmark Cell Processing Laboratory (CPL) Performance
Gorman, E.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Gorospe, G.
Managing of Daily Improvement (MDI) Through Daily Huddles: Creating Culture and Engaged Problem Solving Nurse Coordinator Staff At City of Hope Department of Hematology & Hematopoietic Cell Transplant (HEM/HCT)
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Gorosquieta, A.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Gottlieb, D.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
Gottschalk, S.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Gottschalk, S.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Gourde, J.
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Goutagny, M. P.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Gouveia, R.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
The Cost of Pediatric Unrelated HSCT
Goyal, R. K.
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Granata, A.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Grant, R. A.
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Grant-Navarro, P.
Transforming Change of Shift Handoff: Implementing Walking Rounds in Adult Bone Marrow Transplant
Granzin, M.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Grassi, A.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Gray, J.
A Multidisciplinary Intervention Fosters Dissemination and RAPID Implementation of Evidence Based Medicine
Green, D. J.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Green, G.
Decreasing Readmission Rates in Autologous Stem Cell Transplant Patient for Symptom Management
Green, J.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Green, M. L.
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Gregornik, D.
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Gregory, K.
Evaluation of Post-Transplant Iron Chelation Therapy in Allogeneic Hematopoietic Stem Cell Transplant
Gregory, S. A.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Gregory, T.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Greinix, H.
WBMT Luncheon Symposium: The Legacy of E. Donnall Thomas: 1 Million Hematopoietic Stem Cell Transplants
(ADMIN) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
(PHARM) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
Gress, R.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Grier, D.
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
Griffith, L.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Griffith, N.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Griggs, J. J.
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Grimley, M.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Secondary Hemophagocytic Lymphohistiocytosis (HLH) From a Brown Recluse Spider Bite
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Gross, T. G.
Immunogenecity of Early Post Transplant Vaccination in Children
Oral Abstracts - Session C - Pediatric Disorders
Grossman, A.
Implementation and Maintenance of Practice Guidelines to Decrease Central Line Associated Bloodstream Infections by Minimizing Line Manipulation
Grosso, D.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC)
Gruhn, B.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Grupp, S.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Oral Abstracts - Session H - Pediatric Disorders & GVH/GVL
Guay, M.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Gudritz, K.
Initiation of Cardiac Monitoring On a Blood and Marrow Transplant Unit – an Educational Plan to Provide Continuity of Care for Patients
Transitioning Nurse-to-Nurse Report to the Bedside
Guenda, K.
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Guengoer, T.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Guggiari, E.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Guillaume, T.
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Guimond, M.
The Restorative Effect of Flt3-Ligand and IL-7 On CD4+ T Cell Homeostatic Proliferation During Graft-Versus-Host Disease
Gul, Z.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Gulbis, A.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Guo, H.
Glutathione Redox Metabolomic Dysregulation Precedes TNF-α Elevation and Predicts Severity of Gvhd in Experimental Transplantation
Gupta, M.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Gupta, V.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Designing Individualized Care Plan for Patients with Myelofibrosis
Novel Treatment Options for Myelofibrosis
Novel Treatment Options for Myelofibrosis
Designing Individualized Care Plans for Patients with Myelofibrosis: JAK Inhibitors Versus HCT
Novel Treatment Options for Myelofibrosis
Designing Individualized Care Plan for Patients with Myelofibrosis
Novel Treatment Options for Myelofibrosis
Designing Individualized Care Plan for Patients with Myelofibrosis
Oral Abstracts - Session G - Allogeneic Transplants
Gusha, A.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
Gushiken, F.
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Guthrie, K. A.
Higher Infused CD34+ Dose Positively Influence Platelet Recovery After Cord Blood Transplantation
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Gutierrez-Aguirre, C. H. Sr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Gwede, C.
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known

H

Habermann, T. M.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Hacker, E. D.
Sleep Interrupted: Nocturnal Care Disturbances
Hadi, A.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Hadid, T.
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Haggerty, J.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Haile, D. J.
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Haining, W. N.
Defining the Molecular Phenotype of Virus-Specific T Cells
Hakim, F.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Hall, M.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Halverson, D.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Hamadani, M.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Hamby, K.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Hamdi, A.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Hamerschlak, N.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Hamidieh, A. A.
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Hamidieh, A. A.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Hamilton, B. K.
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Hamlin, D. K.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Hamlin Paul, P.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Hamm, D.
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Han, K. L.
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
Han, T. T.
Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation
Han, W.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Han, Y.
Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Hanash, A. M.
Oral Abstracts - Session I - GVH/GVL & Hematopoiesis/Mesenchymal Cells
Hanash, S.
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Handgretinger, R.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Hänel, M.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Hanna, R.
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Hannon, M.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Hansen, J. A.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
Hanson, I. C.
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Harden, K. L.
Initiation of Cardiac Monitoring On a Blood and Marrow Transplant Unit – an Educational Plan to Provide Continuity of Care for Patients
Hardy, N.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Hari, P. N.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Final Outcomes of Escalated Melphalan 280 MG/M2 Prior to Autologous Hematopoietic Cell Transplantation for Multiple Myeloma (MM) : High CR+VGPR Rate Does Not Translate Into Improved Survival
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
(PHARM) Saturday Scientific Luncheon Symposium: Clinical Advances in the Management of Myelofibrosis
Autologous Transplant for Multiple Myeloma - Does Early Transplant Still Make Sense?
Management of Multiple Myeloma Patients
BMT Tandem Luncheon Symposium: Clinical Advances in the Management of Myelofibrosis
BMT Tandem Luncheon Symposium: Clinical Advances in the Management of Myelofibrosis
Stem Cell Transplantation in the Era of JAK Inhibitors: Putting the Pieces Together
Stem Cell Transplantation in the Era of JAK Inhibitors: Putting the Pieces Together
Stem Cell Transplantation in the Era of JAK Inhibitors: Putting the Pieces Together
Stem Cell Transplantation in the Era of JAK Inhibitors: Putting the Pieces Together
Multiple Myeloma: Novel Agents Transplantation and Future Directions
BMT Tandem Luncheon Symposium: Clinical Advances in the Management of Myelofibrosis
Harnicar, S.
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Harrelson, R.
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
Harrington, E.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
Harris, A. C.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Harris, M. J.
Providing Cultural Competent Care
Harris, M.
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Harrison, D.
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Harrison, L.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Hars, V.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Hart, D. N.
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Hart, J.
Who and When to Chelate in HCT
Hart, L.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Hartford, C. M.
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Hartzman, R.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Harvey, E.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Harvey, R. D.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Hasan, A. N.
Epitopes of CMVpp65 Co-Presented by Multiple Allelic Variants of HLA Class-I Antigens: Implications for Adoptive Immunotherapy for CMV Using Third Party Donor –Derived CMV Specific CTLs
Hasbal, B.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
Hashmi, S.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Hassballah, A.
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Hassebroek, A.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Hassoun, H.
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
Haut, P.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Hawkins, D.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Hayashi, J.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Hayashi, M.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Hayashi, R.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Neurocognitive Function in Pediatric Stem Cell Transplant Recipients Following Low Dose Single Fraction Total Body Radiation and Cyclophosphamide
Hayden, R. T.
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Hayek, C.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Hayes-Lattin, B.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Hayman, S.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Hayslip, J.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Hazlett, A. F.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Hedayat, M.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Hegner, M.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Heilmann, C.
Female Fertility After Allogeneic Stem Cell Transplantation in Denmark. A National Cohort Study
Heimfeld, S.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Heineman, T.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Heitner, S.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Chronic Gvhd-Associated Serositis and Pericarditis
Held, P.
Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate
Held, V.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Heller, G.
Statistical Methods for Biomarker Exploration
Helms, T.
Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation
Hemmati, P.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Hennelly, C.
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Hennig, T.
Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation
Hensel, N.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Hente, M.
Incidence and Mechanism for Decreasing Central Catheter Contamination of Calcineurin Inhibitors in Stem Cell Transplant Patients Utilizing an Educational Intervention
Henzan, H.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Hermanson, J.
Young Male Donors Provide the Best Chance of Meeting Requested Cell Dose for PBSC and Bone Marrow Transplantation
Hernandez, B.
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Hernandez, MBA, J.
Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
Herrera, A.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Hertzberg, M.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
Herzog, J.
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Heslop, H. E.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Heslop, H. E.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
BI-Specific T CELL Therapy for Pancreatic Cancer
Haploidentical Transplantation in 2013
Hess, A. D.
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Hester, J.
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Hexner, E. O.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Hiemenz, J.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Highet, A. M.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Hildebrandt, G. C.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Azithromycin Induces the Expansion of Regulatory T Cells and Diminishes Alloreactive T Cell Proliferation in Vitro and in Vivo
Hill, B.
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Hill, G.
Oral Abstracts - Session E - GVH/GVL
Hillgruber, R.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Hindi, H. F.
BI-Specific T CELL Therapy for Pancreatic Cancer
Hindilerden, F.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
Hirner, A.
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Hirsch, B.
G-CSF, Donors and Chromosomes: Addressing the Question of Genomic Instability
Hirsch, I.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Hirsch, R.
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Ho, A. D.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Ho, V. T.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
(WC) Regimen-Related Toxicity and Supportive Care
Hochberg, E.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Hochberg, F.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Hoffmann, R.
The Impact of Exercise On Hematopoietic Stem Cell Transplant Patients
Hofmeister, C. C.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Hofmeister, C. C.
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Hogan Edwards, K.
Evaluation of Blood Pressure Medication Use Associated with Cyclosporine-Induced Hypertension in the Allogeneic Bone Marrow Transplant Population
Hogan, W.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Hohl, T.
The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis
Holladay, M.
NKG2D Ligands in Pediatric Cancer
Holland, H. K.
Maintenance Hypomethylating Therapy Post Allogeneic Stem Cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous Leukemia or Non Responsive Myelodysplastic Syndrome
Holtan, S.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Chronic Gvhd-Associated Serositis and Pericarditis
Holter Chakrabarty, J.
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Retrospective Analysis of Intravenous DMSO Toxicity in Transplant Patients
Holter, J.
Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant
Holter, W.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Hong, J.
Evaluation of Pre-Transplant Risk Factors of Bacterial Bloodstream Infection (BSI) in Patients with Hematopoietic Stem Cell Transplantation (HSCT) and Comparison of BSI Between Allogenic and Autologous HSCT
Hongeng, S.
Novel Reduced Toxicity Conditioning Regimen for Older Severe Thalassemia Patients: Sequential Immunoablative Concept
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Hook, K. P.
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Hoover, E.
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
PI and Site Coordinator Protocol Adherence Panel
Horan, J.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Hordinsky, M. K.
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Horn, B.
Recovery of Lymphocyte Function May Predict Risk of Leukemic Relapse in Pediatric Patients Undergoing Allogeneic Stem Cell Transplant
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies
Hornback, A.
Improving Patient Satisfaction in the Outpatient BMT Clinic Setting
Horne, A.
Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure
Horne, B.
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Hornick, J.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Horowitz, M.
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Horowitz, M. M.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Welcome Address
Welcome Address
BMT CTN Update
High-Level Overview of Ways to Get Involved in Research (Observational Studies, Research Repository Resource, BMT CTN)
Horwitz, E. M.
MSCs for Bone Repair
Oral Abstracts - Session K - Immune Reconstitution & Clinical Cellular Therapy
(WC) Immune Deficiencies/Inborn Errors
Horwitz, M. E.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Hosing, C.
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Hosoda, T.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Hosseini, A. S.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Hou, G.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
Hou, J. Z.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Hourigan, C. S.
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Howard, D.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Howell, J.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Howrie, D.
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Hsieh, L.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Hsieh, M.
Allogeneic HCT in Sickle Cells Disease: When and How
Hsu, A.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Hsu, J.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Hsu, S.
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Htut, M.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Hu, L.
Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Hu, Z.
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
Huang, A. Y. C.
Dynamic Assessment of Cellular Mobilization, Homing and Interaction in the Tissue and Bone Marrow Niche at a Single-cell Level
Huang, C. A.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
The MGH Miniature Swine As a Large Animal Model of HCT and Graft Versus Host Disease
Huang, G.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
Huang, X. J.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Huber, E.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Hudspeth, M.
Immune Reconstitution & Vaccine Response After Pediatric Allo-HSCT
Hull, D.
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Huls, H.
Capitalizing On Epitope Escape to Avoid T Cell Fratricide without Compromising Targeting of CD56+ Tumors
Humblet, S.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Huneke, T.
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Huntsinger, L.
Early Identification of HCT Patient Discharge Needs
Huppert, V.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate
Hurley, A.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Hurley, C. K.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Hurton, L. V.
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Hutton, G. J.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Huynh, V.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Hwang, J.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Hylarides, M. D.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model

I

Ibanez, A.
The Cost of Pediatric Unrelated HSCT
Ibrahim, K.
Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure
Idrissi, M.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Ikegame, K.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Risk Analysis of Falls in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Im, A.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Inamoto, Y.
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Innis-Shelton, R.
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Inoue, M.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Inoue, T.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Introna, M.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Inwards, D. J.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Iovino, C.
Vaccine Responses Following Unrelated Double Cord Blood Transplantation (CBT)
Irenze, K.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Ishii, S.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Ishiwata, K.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Iskas, M.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Isola, L.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Ito, S.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Ito, Y.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Itoh, M.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Ivison, S.
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
Iwarsson, E.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Iwasaki, H.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Izutsu, K.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation

J

Jacob, E. K.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Jacobs, D.
Ocular Chronic Gvhd: Increasing Opportunities for Impact and Awareness
Jacobs, J.
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Jacobsen, P.
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Jacobsohn, D. A.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
(WC) Late Effects and Quality of Life
Jadali, F.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Jagannath, S.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Jagasia, M. H.
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Jagirdar, N.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Jaglowski, S.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Jaimovich, G.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Jain, N. A.
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Jaiswal, S.
Persistently High Gam Levels Are Associated with Nonrelapse Mortality in HCT Recipients Irrespective of Invasive Aspergillosis: A Prospective Cohort Study
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Second Haploidentical PBSC Transplantation From the Same Donor After Early Relapse without Gvhd in Patients with Acute Leukemia
Jakobsen, B.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Jakubowski, A. A.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Incidence and Kinetics of CMV Infection After T-Cell Depleted and Unmodified Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience At Memorial Sloan-Kettering Cancer Center
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Comparison of GRAFT Content and Outcomes in BONE Marrow and PBPC Grafts After T CELL Depletion by Three Different Methods
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Jakubowski, R. M.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Where Does Granulocyte Colony Stimulating Factor Use Stand Following Allogeneic Hematopoietic Stem Cell Transplant in 2012
Jalali, A.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Jamieson, C.
Malignant Reprogramming: Biological and Therapeutic Implications
Janakiraman, N.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
Janssen, W.
Regulatory T CELLS Specific for Minor Histocompatibility Antigens
Jarisch, A.
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Jaroscak, J.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Jasem, J.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Jawanda, J.
Process for Selecting an Information Technology Vendor that can Enable Operational Excellence, Efficiency, and Effective Reporting for Blood Marrow Transplant Programs
Jeannet, L.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Jehn, C.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Jenkins, J.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Jenkins, T.
2012 BMT ICU Utilization Project Update
Jensen, M. C. V.
Enhancing the IQ of Chimeric Antigen Receptor Redirected T Cells
Jerome, K.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Ji, Y.
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Jillella, A.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Jim, H.
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Jimenez, V.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Jin, Z.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
Allogeneic Stem Cell Transplant for Children with Sickle Cell Disease Reduces Healthcare Utilization
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Jodele, S.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Joffe, S.
(WC) Health Policy and Psychosocial Issues
Johnson, D.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Johnson, H. R.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Johnson, K.
Implementation and Maintenance of Practice Guidelines to Decrease Central Line Associated Bloodstream Infections by Minimizing Line Manipulation
Johnson, N.
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Johnson, S.
Managing of Daily Improvement (MDI) Through Daily Huddles: Creating Culture and Engaged Problem Solving Nurse Coordinator Staff At City of Hope Department of Hematology & Hematopoietic Cell Transplant (HEM/HCT)
Johnston, L.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Johnston, P. B.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Jol-van der Zijde, E.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Jones, C. D.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Jones, D.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Jones, L.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Jones, N.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Jones, R. J.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Pediatric Patients with High Risk Hematologic Malignanices
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Jones, R. B.
Beyond Electronic Data Capture (EDC) to Data Sharing: Update of ASBMT/CIBMTR/NMDP IT Programs
Jones, S.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Jongwutiwes, U.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Incidence and Kinetics of CMV Infection After T-Cell Depleted and Unmodified Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience At Memorial Sloan-Kettering Cancer Center
Joo, J.
Hand-Foot Syndrome (HFS) in Hematopoietic Stem Cell Transplant (HSCT) Patients: Effect of Total Body Irradiation (TBI), Etoposide (VP16) and Palifermin
Jordan, K.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Jordan, M.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Jorgensen, J. L.
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Joseph, T. L.
Test - Tlj
Joyce, R.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Juckett, M.
Practice Improvement Module Demo
Jude, V. H.
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
June, C. H.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Engineered T Cell with CARs and TCRs for Hematologic Malignancy
Jung, J.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Jungbluth, A. A.
CT7/MAGE-C1 Expression and Immune Responses Following Allogeneic Transplant for Multiple Myeloma
Justesen, S.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2

K

Kady, N.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Kagoo, T.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Kaida, K.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Kaipe, H.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Kakarla, S.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Kakhniashvili, I.
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC)
Kalaycio, M. E.
Five Innovations in BMT Clinical Research Process
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Decreasing Readmission Rates in Autologous Stem Cell Transplant Patient for Symptom Management
Description of Adverse Drug Events Associated with High-Dose Undiluted Etoposide (VP-16) Among Hematopoietic Stem Cell Transplant Recipients
Multiple Myeloma
(WC) Chronic Leukemia
Kalos, M.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Kaloyannidis, P.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Kalpatthi, R.
Utilization and Outcome of Bone Marrow Transplantation in Children with Sickle Cell Disease: A Pediatric Health Information System Database Analysis
Kamani, N.
Current Attitudes of Parents and Patients towards Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
BMT CTN 0601: Sickle Cell
Kamble, R.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Kamimura, T.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Kaminetzky, D.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Kanakry, C. G.
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Oral Abstracts - Session K - Immune Reconstitution & Clinical Cellular Therapy
Kanate, A.
Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Kanate, A. S.
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Kanathezhath, B.
Glutathione Redox Metabolomic Dysregulation Precedes TNF-α Elevation and Predicts Severity of Gvhd in Experimental Transplantation
Kanda, J.
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Kanda, Y.
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Kang, E.
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
Kang, G.
Elevated Gamma Delta T Cell Recovery Following Hematopoietic Stem Cell Transplantation Associated with Improved Long Term Overall Survival in Pediatric Patients with Acute Leukemia
Kang, M.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Kang, Y.
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
Kanphade, G.
The Effect of Exercise Compliance in Patients Undergoing Hematopoietic Stem Cell Transplantation On Their Functional Capacity During Their Hospitalization
Kao, G.
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Kaplan, L. D.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Kapoor, P.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Karanes, C.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Kariminia, A.
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
Karlsson, F. J.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Azithromycin Induces the Expansion of Regulatory T Cells and Diminishes Alloreactive T Cell Proliferation in Vitro and in Vivo
Karmali, R.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Karur, V.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Karypidis, K.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Kaskel, P.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Kasner, M.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Kasow, K. A.
Supporting Siblings Through the Allogeneic Hematopoietic Cell Transplant Process: The Perspectives of Minor and Young Adult Siblings of Successful Transplant Recipients
Autologous Hematopoietic Cell Transplantation Can Prolong Life in High-Risk Neuroblastoma Patients in Partial Remission
Katari, U.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Kato, J.
Safety of Coadministaraion of Teicoplanin and Tacrolimus After Allogeneic Hematopoietic Stem Cell Transplantation
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG
Kato, K.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Kato, K.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Kato, K.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Kato, R.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Katz, J.
Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Katz, T.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Kaufman, J.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Kawano, Y.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Kawase, T.
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Kayikci, O.
BEAM or ICE?
Kean, L. S.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
New Insights into the Immunology of Transplant Tolerance using a Non-human Primate Model
(PEDS) Viewing Transplant Immunology through Today's Lens: New Models, New Imaging and New Insights
Keating, A.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Keating, A.
Overview of MSCs
Hot Topics in MSCs
(WC) Cellular Therapy
Kebriaei, P.
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
MSCs for GVHD
Keding, A.
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Keene, D. R.
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Keirnan, J.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Kelemen, K.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Keler, T.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Kelher, M. R.
Pediatric Post Transplant Neutrophil Function
Keller, J. W.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Kelley, A.
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Kelly, M.
Autologous Stem Cell Collection for the Treatment of Malignant Diseases in Pediatric Patients: The Use of the Power Hickman
Kemp, T. J.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
Kempenich, J.
Young Male Donors Provide the Best Chance of Meeting Requested Cell Dose for PBSC and Bone Marrow Transplantation
How Much Is Enough? Ethical Consideration for the Depletion of Large Public Cord Blood Units (CBU)
Kempert, P.
Same Sibling Marrow Following Cord Allogeneic Transplantation As Therapy for Second Relapse APL: A Pediatric Case Report
Kendrick, S.
Transplant: The Ultimate Team Sport. A Potential Answer to Workforce Challenges in Hematopoietic Stem Cell Transplant
Kennedy, K.
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Kennedy, R.
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Kennedy-Nasser, A.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Improvement in Early Recognition of Deteriorating Pediatric Bone Marrow Transplant Patients
Kennel, M.
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
Kenoyer, A.
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Kent, M. W.
Pediatric Post Transplant Neutrophil Function
Kenzey, C.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Kerbauy, F. R.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Th17-Related Gene Rorγt Overexpressed in Patients with Chronic Gvhd: New Insights for T-Cell Manipulation and Gvhd Control
Oral Abstracts - Session A - Allogeneic Transplants
Kernan, N. A.
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Keyvanfar, K.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Keyzner, A.
Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation
A Single Institution's Experience Utilizing Augmented CBV for Patients with Relapsed Diffuse Large Cell Lymphoma Undergoing Autologous Stem Cell Transplantation
Khaled, S. K.
Clofarabine and High-Dose Melphalan As Reduced Intensity Conditioning in Adults with High-Risk Leukemia/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Khaled, Y.
Plasma Cell CD20 Expression: Primary Aberrant Expression or Receptor up-Regulation
The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Leukocytosis Post Engraftment Is Associated with Increased Mortality Among Adult Allogeneic Hematopoietic Cell Transplant (HCT) Reciepients
Khalil, A.
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
Khalil, M. O.
Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant
Khan, F.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Khan, M.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Khan, S.
Outcome of Second Transplants in Pediatric Patients with Hematological Malignancies After a Hematopoietic Stem Cell Transplant (HSCT) From a Different Donor. Assessment of Chimerism by Real -Time PCR to Determine the Risk of Relapse
Khan, S. P.
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Practice Improvement Module Demo
Khan, T.
Effectiveness of an Algorithm-Based Approach to Filgrastim-Based Mobilization Using Predetermined Decision Points for the Inclusion of Plerixafor
Utilization of an Algorithm for Chemomobilization Including the Use of Plerixafor in Poor Mobilizers
Welcome and Overview
Overview
Khandelwal, P.
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Kharbanda, S.
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Khare, N. S.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Kharfan-Dabaja, M.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
Khawandanah, M.
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Khera, N.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Khera, N.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Khoder, A.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Khoury, H. J.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Khoury, J. C.
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Kikushige, Y.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Killi, R.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
Kim, D.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Kim, D. W.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Kim, H.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Kim, H. J.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Kim, J.
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Kim, M. O.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Kim, S.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Kim, S. H. Jr.
The Effect of Sirolimus Based Regimen On Immune Reconstitution After Allogeneic Stem Cell Transplantation
Kim, Y. J.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Kim, Y. H.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Kimura, F.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
King, B.
Implementing Novel Predictive Parameters in Apheresis
Kinsella, T.
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Kirkendall, S. K.
The Ticking Clock, Time to First Antibiotic in a Highly Complex Pediatric Bone Marrow Transplant Ambulatory Setting
Kirkland, K.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Kirov, I.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Development of a Consistent Approach to the Management Chemo/Radiation Induced Dermatitis in Children Undergoing Allogeneic Stem Cell Transplantation
Kiss, T.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Kissell, D.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Kitko, C. L.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
(WC) Pediatric Cancer
Kittan, N.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Kitzler, R.
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Klagholz, S. D.
Loneliness in Transplant Caregivers: Exploration of Related Factors
Klein, A.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Klein, J.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Klein, J. P.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Kletzel, M.
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Standardizing Standard Operating Procedures' (SOP) Manual to Benchmark Cell Processing Laboratory (CPL) Performance
Outcome of Second Transplants in Pediatric Patients with Hematological Malignancies After a Hematopoietic Stem Cell Transplant (HSCT) From a Different Donor. Assessment of Chimerism by Real -Time PCR to Determine the Risk of Relapse
Klinetobe, K.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Klingebiel, T. E.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Klinger, E.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Klisovic, R.
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Klisovic, R.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Klotz, J. K.
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Klumpp, T.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Knight, S.
Clabsi Reduction: No Longer Just an Inpatient Initiative
Knovich, M. A.
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
Kobayashi, K.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Kobayashi, S.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Kobos, R.
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Kochuparambil, S.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Kocoshis, S.
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
Kodera, Y.
WBMT Luncheon Symposium: The Legacy of E. Donnall Thomas: 1 Million Hematopoietic Stem Cell Transplants
(ADMIN) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
(PHARM) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
Koehne, G.
Epitopes of CMVpp65 Co-Presented by Multiple Allelic Variants of HLA Class-I Antigens: Implications for Adoptive Immunotherapy for CMV Using Third Party Donor –Derived CMV Specific CTLs
CT7/MAGE-C1 Expression and Immune Responses Following Allogeneic Transplant for Multiple Myeloma
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Kohashi, S.
Safety of Coadministaraion of Teicoplanin and Tacrolimus After Allogeneic Hematopoietic Stem Cell Transplantation
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG
Kohn, D. B.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Issues in Advancement of HCT Gene Therapy
(PEDS) Hematopoietic Stem Cell Gene Therapy - An Update
Kohrt, H.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Koklanaris, L.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Kolitsopoulos, Y.
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Kolli, S.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Kollman, C.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Kondo, E.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Konstantinou, V.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Koo, D.
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Koo, O. J.
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
Koontz, S. M.
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
Koontz, S. E.
American Society of Hematology (ASH) Rehash
Koralkar, R.
Acute Kidney Injury (AKI) in Pediatric Hematopoietic Stem Cell Transplant Patients Predicts Day 100 Mortality
Koreth, J.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Kornblau, S.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Kornblit, B.
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Kosik, M.
Improving Reliability of Immunosuppressant Sampling Techniques
Koskan, A.
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Kostic, A.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Kota, V.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Kothari, K.
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Kotila, S.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Kovacsovics, T.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Kozawa, M.
Risk Analysis of Falls in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Kozyr, N.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Kraft, G. H.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Krajewski, J.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Krakow, E. F.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Kramer, D.
Suicidal Protocol in Blood and Marrow Outpatient Transplant Setting
Kramer, M.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Krampf, M. R.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Krance, R. A.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Kremens, B.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Krishnamoorthy, R.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Krishnan, A. Y.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Autologous Hemopoietic Stem Cell Transplantation Followed by Allogeneic or Autologous Hemopoietic Stem Cell Transplantation
Autologous Hemopoietic Stem Cell Transplantation Followed by Allogeneic or Autologous Hemopoietic Stem Cell Transplantation
Autologous Hemopoietic Stem Cell Transplantation Followed by Allogeneic or Autologous Hemopoietic Stem Cell Transplantation
(WC) Plasma Cell Disorders
Kristofik, C.
Initiation of Cardiac Monitoring On a Blood and Marrow Transplant Unit – an Educational Plan to Provide Continuity of Care for Patients
Transitioning Nurse-to-Nurse Report to the Bedside
Krivoy, M.
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Kropf, P. L.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Krupka, E.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Kuba, L.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Kuball, J.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Kubota, A.
Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Kucuk, Z. Y.
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
Kufe, D.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Kulkarni, S.
Why Submitting Lab Reports is Important
Kumar, A.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Kumar, S.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Kunter, G. M.
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Kuntz, N.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Development of a Consistent Approach to the Management Chemo/Radiation Induced Dermatitis in Children Undergoing Allogeneic Stem Cell Transplantation
Kuriyama, T.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Kurland, B. F.
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Kurosawa, S.
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Kurtzberg, J.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
BMT CTN 0501: Single vs. Double Cord
Kuruvilla, J.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Kusminsky, G.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Kuypers, J. M.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Kwan, J.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors

L

Labopin, M.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
LaCasce, A.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Lacayo, N.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Lachance, S.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Lachance, S.
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Lacy, M.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Lakshmi, K.
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
Lakshmi, K.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
Lalefar, N. R.
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant
Lam, M.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Lamprecht, M.
A Randomized Study to Compare the Effect of 2-Hour and 6-Hour Schedules of Cryotherapy On the Incidence of Severe Mucositis in High Dose Melphalan
Lan, L.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Landau, E.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Landau, H.
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents
Landau, H.
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Landery, D.
A Multidisciplinary Intervention Fosters Dissemination and RAPID Implementation of Evidence Based Medicine
Laneuville, P.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Langholz, B.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Langston, A.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Lankester, A.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Lanska, M.
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Lanum, S.
Best Practices: Transitions of Care
Laport, G. G.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
Anatomy of a Study: Part One
Anatomy of a Study: Part One
Welcome Address
Role and/or Optimal Timing of HCT for Mantle Cell Lymphoma and TCL
Welcome to BMT CTN
Oral Abstracts - Session M - Lymphoma/Multiple Myeloma
BMT Tandem Luncheon Symposium: Transplant and Non-Transplant Therapies for Mantle Cell and T Cell Lymphomas
(WC) Lymphoma
Lapteva, N.
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
Larratt, L.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Larsen, H.
Female Fertility After Allogeneic Stem Cell Transplantation in Denmark. A National Cohort Study
Larsen, M. E.
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Larsen, M. V.
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Larsen, S.
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Laskin, B.
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Lassiter, M.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
Gorillas in Our Midst
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Welcome
Nutrition - EBP
Latchford, T.
Moving Mobilization Chemotherapy From the Inpatient to the Outpatient Setting
Moving Practice Forward; Standardization of Infusion Times for Hematopoietic Cells Utilizing an IV Pump
Hot Topics
Latshaw, S.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Lau, S.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Laubach, J.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Laughlin, M. J.
(WC) Graft Sources and Manipulation
Lavori, P.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Lawson, A.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Lazo-Kallanian, S.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Le, C.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
le Coutre, P.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Le, K.
Survival Improvements Following Omega-3 Polyunsaturated Fatty Acid Dietary Enrichment, Acetylsalicylic Acid, and Aspirin-Triggered Lipoxin Administration in a Lethal Mouse Model of Acute Graft-Versus-Host Disease
Le-Rademacher, J.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Leadmon, S.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Leather, H.
Continuous Infusion Cyclophosphamide and Low Dose Total Body Irradiation (CICy/ldTBI) As a Conditioning Regimen for Tandem Autologous Transplant in Multiple Myeloma
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
ASBMT Pharmacy SIG / NMDP SCI Update
Lechowicz, M.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Leclere, J.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Lee, A. C. W.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Lee, B.
Utilization and Outcome of Bone Marrow Transplantation in Children with Sickle Cell Disease: A Pediatric Health Information System Database Analysis
Lee, D. A.
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Lee, E. J.
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Lee, J. H.
Evaluation of Pre-Transplant Risk Factors of Bacterial Bloodstream Infection (BSI) in Patients with Hematopoietic Stem Cell Transplantation (HSCT) and Comparison of BSI Between Allogenic and Autologous HSCT
Lee, J. W.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Lee, R.
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Lee, S.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Lee, S.
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Lee, S. J.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Chronic GVHD: What Have We Learned from the Longitudinal Study?
Lee, S. E.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Lee, V.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Lee, Y. J.
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Leeborg, N.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Leen, A. M.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
BI-Specific T CELL Therapy for Pancreatic Cancer
Virus-specific Immune Reconstitution
Lehmann, L.
WHAT Tools ARE in Your Toolbox to Promote Change?
Lehrman, R.
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Leis, J.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Leisenring, W.
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis
LeMaistre, C. F.
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
LeMaistre, C. F.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Introductions
(ASBMT) BMT Medical Directors Conference
Lendvai, N.
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Lenthen, K.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Leonard, J.
Chronic Gvhd-Associated Serositis and Pericarditis
Leonard, K.
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Lermontov, S.
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Leslie, J.
Infectious Diseases Update
Lesokhin, A.
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Lester, J.
A Randomized Study to Compare the Effect of 2-Hour and 6-Hour Schedules of Cryotherapy On the Incidence of Severe Mucositis in High Dose Melphalan
Letai, A.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Leung, D.
Hot Topics
Leung, K.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Leung, N.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Leung, W.
NKG2D Ligands in Pediatric Cancer
Isolation, Expansion & Function of Cord Blood Natural Killer Cells
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Lev, A.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Leveille, S.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Levine, B.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Levine, J. D.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Levine, J.
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
GVH: Early Markers
BMT CTN 1202: Biomarkers
Levine, J. E.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Levy, R.
Lymphoma Immunotherapy: Vaccines, Adoptive Cell Transfer and Immunotransplant
Lewis, I.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
(WC) Cellular Therapy
Lewis, M.
BMT CTN 0801: Chronic GVHD Treatment
Lewis, V.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Lewyckyj, M.
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Leyva, A.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
Lezaic, T.
Reporting Death, 2900 Form
Li, C. F.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Li, E. P.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Li, L.
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Li, Y.
The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Li, Y.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Liacini, A.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Liao, Y.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Liebersbach, S.
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Liewer, S.
GVH: Year in Review
Liliental, J. A.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Lill, M.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Lim, A. B. M.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Lim, M.
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Lim, N.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Lim, S.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Lin, T.
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
Lindemans, C.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Linderman, C.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Link, M.
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Liou, H. C.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Lipscomb, C.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Lipton, J. H.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Lissitsyn, Y.
Survival Improvements Following Omega-3 Polyunsaturated Fatty Acid Dietary Enrichment, Acetylsalicylic Acid, and Aspirin-Triggered Lipoxin Administration in a Lethal Mouse Model of Acute Graft-Versus-Host Disease
Lister, J.
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Anti-Thymocyte Globulin At 6mg/Kg, Not 4.5mg/Kg, Protects From Severe Lethal Graft-Versus-Host Disease
Litzow, M.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Should Targeting MRD in Adult ALL be a Primary Therapeutic Goal prior to Transplant?
Liu, A.
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Liu, C. Y. Y.
Using Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) to Predict Autologous Transplant-Related Toxicities in Elderly Patients Aged 65 or Older
Liu, C.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Liu, D. H.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Liu, H.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Liu, H.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Liu, K. Y.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Lo, L.
Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Loberiza, F. R.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Lobritto, S.
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Locke, F.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Loeb, D.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Pediatric Patients with High Risk Hematologic Malignanices
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Loewen, B.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Loftis, J.
Gorillas in Our Midst
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Logan, A.
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Logan, B. R.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Multistate Models in BMT
The Importance of Safety Data
Novel Statistical Approaches for Bone Marrow Transplant Studies
Logan, K.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Lohr, A.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Long, G.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Long, M.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome
Long-Boyle, J.
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Longo, A.
Therapeutic Relationship Education On a Pediatric Bone Marrow Transplant and Immunology Unit
Longoni, D. V.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Lonial, S.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
(CRP/DM) Wednesday Scientific Luncheon Symposium: Multiple Myeloma Treatments for the Transplant-Eligible and Non-Transplant-Eligible Patient
(BMTCTN) Wednesday Scientific Luncheon Symposium: Multiple Myeloma Treatments for the Transplant-Eligible and Non-Transplant-Eligible Patient
Frontline Treatment of Patients with Multiple Myeloma Who Are Transplant Ineligible
Frontline Treatment of Patients with Multiple Myeloma Who Are Transplant Ineligible
Frontline Treatment of Patients with Multiple Myeloma Who Are Transplant Ineligible
BMT Tandem Luncheon Symposium: Multiple Myeloma Treatments for the Transplant-Eligible and Non-Transplant Eligible Patient
(WC) Plasma Cell Disorders
Lopez Corral, L.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
Lopez-Bover, M.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
Lotero, V.
Post-Transplant Cyclophosphamide Is Feasible and Reduces Acute GvHD in Pediatric UCB Transplantation
Loucks, M.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Lown, R.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Significantly Higher Rates of Donor Attrition in Minority Ethnic, Female and Older Donors: A Review of 7542 Confirmatory Typing Requests at Anthony Nolan
Lowsky, R.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Lozanski, G.
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lubin, M.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Vaccine Responses Following Unrelated Double Cord Blood Transplantation (CBT)
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Lucchini, G.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Lucchini, G.
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Luck, J.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
Luckey, C. J.
Implementing Novel Predictive Parameters in Apheresis
Ludlow, A.
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
Luke, J.
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Lum, L.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Luna-Fineman, S.
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Lund, O.
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Lunghi, F.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Lunning, M. A.
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Luo, C.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Lupo Stanghellini, M. T.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Luptakova, K.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Luther, K.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Lutz, P.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Lutz-Presno, J. A.
Body Mass Index As an Indicator of Prognosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institution Experience
Luznik, L.
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Oral Abstracts - Session L - Allogeneic Transplants
Lv, M.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS

M

Ma, Y.
Towards the Development of a Closed, Nanofiber-Based Culture System for Clinical Expansion of Cord Blood CD34+ Cells
MacDonald, D.
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
MacDonald, K. P. A.
Antigen Presenting Cells and GVHD
Maciejewski, J.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Mackall, C.
Enhancing Immune Responses to Tumor Associated Antigens
Macke, M.
Alcohol Impregnated Caps: Are They Effective for Preventing Clabsi?
Mackinnon, S.
Oral Abstracts - Session L - Allogeneic Transplants
Mackrell, M.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
MacMillan, M. L.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Hematopoietic Cell Transplantation for Acute Leukemia and Advanced Myelodysplastic Syndrome in Fanconi Anemia
Macon, W. R.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
MacPherson, J.
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Sub-Therapeutic Levels of ORAL Tacrolimus Prophylaxis PRIOR to Allogeneic STEM CELL Transplant Do NOT Predict the Incidence of Chronic GRAFT Versus HOST Disease
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Madden, W.
Alcohol Impregnated Caps: Are They Effective for Preventing Clabsi?
Madrigal, A.
Significantly Higher Rates of Donor Attrition in Minority Ethnic, Female and Older Donors: A Review of 7542 Confirmatory Typing Requests at Anthony Nolan
Oral Abstracts - Session D - Allogeneic Transplants
Madtes, D. K.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
Maeda, Y.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Magenau, J.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Vitamin D Supplementation Decreases Grade 3-4 Acute Gvhd in Allogeneic Transplants with Normal Baseline Levels
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Magnum, M.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
Maguire, F.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Mahadeo, K. M.
A Multidisciplinary Intervention Fosters Dissemination and RAPID Implementation of Evidence Based Medicine
Mahmud, N.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Maiers, M.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Maiers, M.
(NMDP) Bioinformatics Research Advisory Ginger Group Meeting
Majeti, R.
Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells Precedes Human AML
Majhail, N. S.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
BMT CTN 1205: Easy to Read Informed Consent
Survivorship Panel
Transplant-Related Complications
Majhail, N. S.
Substantial Variation in Medicaid Coverage for Hematopoietic Cell Transplantation
National Survey of Transplant Center Characteristics
Majhail, N. S.
National Survey of Transplant Center Characteristics
Makino, S.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Malech, H. L.
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
(WC) Immune Deficiencies/Inborn Errors
Malhotra, S.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Mallouri, D.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Malone, A. K.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Maloney, D. G.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
(WC) Lymphoma
Maloy, M.
The Management of Relapsed AML or MDS Following a T-Cell Depleted Allogeneic Stem Cell Transplant
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Maluf, E. C. Sr.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Malvezzi, M.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Mancias-Guerra, C. Sr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Maness, L.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Mangan, K. F.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Mann, J.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Manning-Geiss, B.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Mannone, L.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Mansilla, C.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Mansour Riwes, M.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Maragulia, J.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Marcatti, M.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Marcucci, G.
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Marek, E.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Margolis, D.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Autologous Stem Cell Collection for the Treatment of Malignant Diseases in Pediatric Patients: The Use of the Power Hickman
Margolskee, D. J.
Monitoring Changes in Serum Albumin (SA) Concentrations As an Early and Objective Indicator of Potential CMX001-Associated Gastrointestinal (GI) Adverse Drug Effects
Renal Safety of Broad Spectrum Antiviral CMX001 in the Prevention of CMV Infection Post- Allogeneic Hematopoietic Cell Transplantation (HCT)
Margossian, S.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
WHAT Tools ARE in Your Toolbox to Promote Change?
Marin, D.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Markovic, S. N.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Marks, D.
Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD)
Markstrom, D.
Vitamin D Supplementation Decreases Grade 3-4 Acute Gvhd in Allogeneic Transplants with Normal Baseline Levels
Marktel, S.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Marmer, D. J.
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Marques, M.
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Marri, P.
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Marsh, R. A.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Martenson, J. A.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Martin, E.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Martin Lopez, A. A.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
Martin, M. E.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Martin, P. J.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Martin, T. G.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Martinez, C.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Martinez, M.
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Martinez Rolon, J.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Martinez, U.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Marty, F.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Marvaki, A.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Masciocchi, F.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Mason, K.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Massenkeil, G.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Mastaglio, S.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Mata, M.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Matar, A. J.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
Matasar, M.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Mathew, S.
Hepatitis in HCT
Mathews, V.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
Matlack, M.
CIBMTR Hot Topics
Matsuoka, K. I.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Matsuoka, K. I.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Matthes-Leodolter, S.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Mattsson, J.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Mauad, M. A.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Maurice, L.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Mawad, R.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
May, R.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Mayer, J.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Maziarz, R. T.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
(WC) Chronic Leukemia
McAfee, S. L.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
McArthur, J.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
McBride, A.
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
McCarthy, P. L.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Consolidation or Maintenance after Transplantation
Translating Clinical Findings into Practice: Primary and Maintenance Therapy for Transplant Candidates
Translating Clinical Findings into Practice: Primary and Maintenance Therapy for Transplant Candidates
Translating Clinical Findings into Practice: Primary and Maintenance Therapy for Transplant Candidates
(WC) Regimen-Related Toxicity and Supportive Care
McCarty, J. M.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
McCaul, K.
Autologous Transplantation As Consolidation Therapy for Primary and Secondary CNS Lymphoma- A Single Center Experience
McCormick, S.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Mccrea, K.
Immunogenecity of Early Post Transplant Vaccination in Children
McDonagh, K. T.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
McDonald, C.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
McDonald, G. B.
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
McDonald, L.
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
McDonough, S. M.
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
McGinty, H.
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
McGrady, M. E.
Adherence to the Outpatient Oral Medication Regime in Adolescent HSCT Recipients
McGrath, J. A.
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
McGuinn, C.
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
McGuirk, J.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
McKay, T. M.
Cibmtr Data Management Training Survey 2012
Mckibben, K.
Bridging the Silos: Utilizing the Lean Model Rapid Improvement Event to Improve the Mobilization Process
McKinnon, R.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
McLaughlin, I. J.
Research Qpcr Method for Engraftment Monitoring: A 6-Year Review of Proficiency Testing Results
McLaughlin, L.
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
McLeod, A.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
McMaster, R.
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
McMillen, K.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
McNiece, I.
MSCs for Cardiac Disease
McPhail, L.
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
McSweeney, P.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Standardizing Education and Competencies Across A Network
Meagher, R.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Mearin, L.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Medeiros, L. J.
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Medeiros, L. Jr.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Mehta, A.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Mehta, J.
Polymicrobial and Multiple Microbiologically Proven Infections in HSCT Recipients
Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Features of Acute Cutaneous Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Mehta, P. A.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Bone Marrow Transplant for Non-Malignant Disorders
(PEDS) International Session: BMT for Thalassemia in Developing Countries
Meier, E. R.
Current Attitudes of Parents and Patients towards Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia
Factors Impacting Family Decisions to Pursue Transplantation for Children with Sickle Cell Disease
Meiers, S.
Welcome / Staff Introductions
Meisel, R.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Melenhorst, J.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Melinamani, S.
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Mellor-Heinke, S.
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Mendelsohn, J.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Mendizabal, A.
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Menten, C.
Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
Merchant, M.
Standardizing Standard Operating Procedures' (SOP) Manual to Benchmark Cell Processing Laboratory (CPL) Performance
Merkel, D.
A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
Merritt, W. D.
ASBMT Public Service Award & Other Awards
Merten, J.
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Best Practices: Collaborative Practice Agreements
Mesa, R. A.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Myelofibrosis: Diagnosis, Classification, Prognosis, and Molecular Etiology
Myelofibrosis: Diagnosis, Classification, Prognosis, and Molecular Etiology
Myelofibrosis: Diagnosis, Classification, Prognosis, and Molecular Etiology
Myelofibrosis: Diagnosis, Classification, Prognosis, and Molecular Etiology
Messina, C.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Messner, H.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Meyer, E. H.
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Meyers, G.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Meyerson, M.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Meyran, D.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Mi, T.
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Mialou, V.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Micallef, I. N.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Michallet, M.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Michel, G.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Micklethwaite, K.
Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic CELLS From Haploidentical Related Donors
Mico, M. C.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Middeke, J. M.
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Mielcarek, M.
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
Mikhael, J.
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Miklos, D. B.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
(WC) Immunobiology
Mikulandric, N.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
Milano, F.
Higher Infused CD34+ Dose Positively Influence Platelet Recovery After Cord Blood Transplantation
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Militano, O.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Advances in Transplantation for Sickle Cell Disease and Beta-Thalassemia
Miller, J. P.
Young Male Donors Provide the Best Chance of Meeting Requested Cell Dose for PBSC and Bone Marrow Transplantation
Mills, H.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Milpied, N.
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Milton, D.
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Min, C. K.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Min, W. S.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Minas, N. M.
A Culture of Continuous Quality Improvement Improves Registry Data
Mineishi, S.
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Miner, S.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Miranda, E.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Mishra, A.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Mishra, B.
Persistently High Gam Levels Are Associated with Nonrelapse Mortality in HCT Recipients Irrespective of Invasive Aspergillosis: A Prospective Cohort Study
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Second Haploidentical PBSC Transplantation From the Same Donor After Early Relapse without Gvhd in Patients with Acute Leukemia
Misquith, R.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Mitchell, D.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Mitchell, R.
Hematopoietic Cell Transplantation for Acute Leukemia and Advanced Myelodysplastic Syndrome in Fanconi Anemia
Mitchell, S.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Mitra, L.
Loneliness in Transplant Caregivers: Exploration of Related Factors
Miyamoto, J.
Risk Analysis of Falls in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Miyamoto, T.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Miyamura, K.
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Miyazaki, K.
High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis –Single Institute Analysis of 35 Cases–
Modak, S.
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Moeller, I.
Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Moghadasian, M.
Survival Improvements Following Omega-3 Polyunsaturated Fatty Acid Dietary Enrichment, Acetylsalicylic Acid, and Aspirin-Triggered Lipoxin Administration in a Lethal Mouse Model of Acute Graft-Versus-Host Disease
Mohty, M.
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Mommeja-Marin, H.
Monitoring Changes in Serum Albumin (SA) Concentrations As an Early and Objective Indicator of Potential CMX001-Associated Gastrointestinal (GI) Adverse Drug Effects
Renal Safety of Broad Spectrum Antiviral CMX001 in the Prevention of CMV Infection Post- Allogeneic Hematopoietic Cell Transplantation (HCT)
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Monahan, G. P.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Monreal, J.
Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Montes de Oca, V.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Montesinos, P.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Montoto, S.
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
(WC) Lymphoma
Mookerjee, B.
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC)
Moore, J.
Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure
Moore, T. B.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Same Sibling Marrow Following Cord Allogeneic Transplantation As Therapy for Second Relapse APL: A Pediatric Case Report
Moorhead, M.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Moorman, M.
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Moravec, C.
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Late Complications after Transplant: Diagnosis and Treatment
Morawa, E.
The Management of Relapsed AML or MDS Following a T-Cell Depleted Allogeneic Stem Cell Transplant
Moreb, J.
Continuous Infusion Cyclophosphamide and Low Dose Total Body Irradiation (CICy/ldTBI) As a Conditioning Regimen for Tandem Autologous Transplant in Multiple Myeloma
Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Relapsed After Initial Autologous Hematopoietic Cell Transplantation
Moreira, M. C. R.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Morgner, A.
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Mori, R.
Risk Analysis of Falls in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Mori, T.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Safety of Coadministaraion of Teicoplanin and Tacrolimus After Allogeneic Hematopoietic Stem Cell Transplantation
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG
Mori, Y.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Morishima, Y.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Morris, A.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Morris, C.
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Morris, E.
Staff Registered Nurses On the Blood and Marrow Transplant Unit: Their Practice and Self-Care Needs
Morris, E.
Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of Agvhd
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Morris, J.
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Morris, L.
Maintenance Hypomethylating Therapy Post Allogeneic Stem Cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous Leukemia or Non Responsive Myelodysplastic Syndrome
Morrison, C. F.
Therapeutic Relationship Education On a Pediatric Bone Marrow Transplant and Immunology Unit
Staff Registered Nurses On the Blood and Marrow Transplant Unit: Their Practice and Self-Care Needs
Mortari, A.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Mortellite, J.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Mortensen, B. K.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Moscoso, S.
Incidence and Mechanism for Decreasing Central Catheter Contamination of Calcineurin Inhibitors in Stem Cell Transplant Patients Utilizing an Educational Intervention
Moskowitz, C. H.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Salvage Strategies for Relapsed DLBCL
Mossad, S. B.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Mossoba, M.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Mucharla, R.
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
BI-Specific T CELL Therapy for Pancreatic Cancer
Mueller, C. R.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
(WC) Immunobiology
Mueller, M.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Mueller, S.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Mulberry, M.
Autologous Stem Cell Collection for the Treatment of Malignant Diseases in Pediatric Patients: The Use of the Power Hickman
Mullin, J. A. H.
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Munaretto, M.
Bridging the Gap – Educating and Preparing a Medical Oncology Unit to Care for the Stem Cell Transplant Patient
Munshi, N. C.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Novel Targets and Novel Agents
Muranski, P.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Muraro, P. A.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
(WC) Autoimmune Diseases
Murase, K.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Murphy, E.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
Murphy, G. F.
The MGH Miniature Swine As a Large Animal Model of HCT and Graft Versus Host Disease
Murphy, P.
Recovery of Lymphocyte Function May Predict Risk of Leukemic Relapse in Pediatric Patients Undergoing Allogeneic Stem Cell Transplant
Murray, D.
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Murray, L.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Muta, T.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Myers, D.
Oral Abstracts - Session C - Pediatric Disorders
Myers, K.
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute Gvhd in Patients with HLH and XLP Undergoing Allogeneic HCT
Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Mytilineos, J.
Missing KIR-Ligands in Single Mismatched Unrelated Hematopoietic Stem Cell Transplantation

N

Na, I. K.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Nabhan, S.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Nabhan, S. Jr.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
NageswaraRao, A.
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Nagler, A.
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients with Chemo-Sensitive Disease and with Treosulfan-Based Conditioning
Nagy, G.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome
Naik, S.
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
Naik, S.
Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Nakagawa, Y.
High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis –Single Institute Analysis of 35 Cases–
Nakamura, R.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Nakano, N.
Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Nakashima, S. S.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Nakasone, H.
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Namdaroglu, S.
BEAM or ICE?
Narita, M.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Nash, R.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Nath, R.
Autologous STEM CELL Transplant (ASCT) As an Effective POST-Remission Consolidation Strategy for Good Risk ACUTE Myeloid Leukemia (AML) Patients
Nathan, S.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Nava, S.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Navarro, W. H.
Young Male Donors Provide the Best Chance of Meeting Requested Cell Dose for PBSC and Bone Marrow Transplantation
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
NMDP Session - Donor Issues
Nayak, L.
Phase II Trial of High-Dose Rituximab with Thiotepa / Busulfan / Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma
Neal, D.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Negrin, R.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Role of Different Cell Products
Nellore, A.
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Nelson, A. S.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Nelson, A.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Nelson, C.
BMT CTN 0702: Myeloma
BMT CTN 0702: Myeloma
Neme, K.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
Nemecek, E.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Neto, J. Z.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Neudorf, S. M.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Development of a Consistent Approach to the Management Chemo/Radiation Induced Dermatitis in Children Undergoing Allogeneic Stem Cell Transplantation
Neumann, J.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
Patients' Expression of Treatment Outcome Uncertainty and Risk Before, During and After Stem Cell Transplantation
Neven, B.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Newell, L. F.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
Newlon, S.
Bridging the Silos: Utilizing the Lean Model Rapid Improvement Event to Improve the Mobilization Process
Newman, N. W.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Newsham, A.
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Nguy, S.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Ngwube, A.
Neurocognitive Function in Pediatric Stem Cell Transplant Recipients Following Low Dose Single Fraction Total Body Radiation and Cyclophosphamide
Nicholas, S. K.
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Niederwieser, D.
(PHARM) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
Niederwieser, D.
WBMT Luncheon Symposium: The Legacy of E. Donnall Thomas: 1 Million Hematopoietic Stem Cell Transplants
(ADMIN) WBMT Session: Legacy of E. Donnall Thomas: 1,000,000 Transplants
Nieto, Y.
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Nieves, D.
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Nikiforow, S.
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Nishida, A.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Nishihori, T.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Nishimori, H.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Nishinohara, M.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Nista, E.
Signature Authentication
Noel, L.
Challenges to Future Growth: The WHO Perspective
Challenges to Future Growth: The WHO Perspective
Challenges to Future Growth: The WHO Perspective
Noel, P.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Nogueira, I. E.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Nonas, S.
Chronic Gvhd-Associated Serositis and Pericarditis
Nooka, A.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Nortman, S.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Norville, R.
Improvement in Early Recognition of Deteriorating Pediatric Bone Marrow Transplant Patients
Notarangelo, L. D.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Novak, K.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Nowakowski, G. S.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Noyes, K.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Nuechterlein, B.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Nugent, D. J.
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Nugent, D. J.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Nunes, E. C. Sr.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning

O

O'Brien, T. A.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Upfront Calcineurin Inhibitor Dose Reduction of 40% in Pediatric Haematopoietic Stem Cell Transplant Does Not Result in Increased Graft Versus Host Disease in Patients Receiving Voriconazole Maintenance Therapy
O'Donnell, P. V.
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
BMT CTN 1101: Haplo vs. Double Cord
BMT CTN 1101: Haplo vs. Double Cord
(WC) Donor Health and Safety
O'Dwyer, C.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
O'Neill, C.
CIBMTR IT Update
Electronic Data Exchange: Current and Future Capabilities
O'Reilly, R.
Epitopes of CMVpp65 Co-Presented by Multiple Allelic Variants of HLA Class-I Antigens: Implications for Adoptive Immunotherapy for CMV Using Third Party Donor –Derived CMV Specific CTLs
CT7/MAGE-C1 Expression and Immune Responses Following Allogeneic Transplant for Multiple Myeloma
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Oates, K.
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Odem, P.
Improving Reliability of Immunosuppressant Sampling Techniques
Standardizing Education and Competencies Across A Network
Ogawa, H.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Risk Analysis of Falls in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Ogilvie, A.
Significantly Higher Rates of Donor Attrition in Minority Ethnic, Female and Older Donors: A Review of 7542 Confirmatory Typing Requests at Anthony Nolan
Oh, A.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Ohashi, K.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Ohashi, K.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Ojesina, A.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Ok, C. Y.
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Oka, H.
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Okada, M.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Okamoto, S.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Okamoto, S.
Safety of Coadministaraion of Teicoplanin and Tacrolimus After Allogeneic Hematopoietic Stem Cell Transplantation
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG
Okamoto, Y.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Oku, S.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Olavarria, E.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Olin, R. L.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Olivares, S.
Capitalizing On Epitope Escape to Avoid T Cell Fratricide without Compromising Targeting of CD56+ Tumors
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Oliveira, M. M.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Oliveira, V.
The Cost of Pediatric Unrelated HSCT
Olsen, J.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Olson, A. L.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Olson, E.
Welcome
Olszewski, M.
Outcome of Second Transplants in Pediatric Patients with Hematological Malignancies After a Hematopoietic Stem Cell Transplant (HSCT) From a Different Donor. Assessment of Chimerism by Real -Time PCR to Determine the Risk of Relapse
Onizuka, M.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Openshaw, H.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Opipari, A. W.
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Oran, B.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Orange, J.
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Orchard, P.
Transplantation for Adrenoleukodystrophy: Considerations and Challenges
(PEDS) Metabolic Disorders
Orlowski, R.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Orozco, J. J.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Orozco, J. J.
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Osborn, M. J.
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Oshima, K.
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Osman, K.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Ostadali, M.
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Ostendorf, B.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Østerby, T.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Ostrem, M.
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Oswald, C.
Upfront Calcineurin Inhibitor Dose Reduction of 40% in Pediatric Haematopoietic Stem Cell Transplant Does Not Result in Increased Graft Versus Host Disease in Patients Receiving Voriconazole Maintenance Therapy
Ota, H.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Otani, J.
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Ouache, M.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
ouachée Chardin, M.
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Ouachee-Chardin, M. Sr.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Oudin, C.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Ours, C.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Ovchinsky, N.
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Owsley, E.
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Ozawa, Y.
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Ozcelik, T.
Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
Ozkaynak, M. F.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia

P

Pack, M.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Paczesny, S.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
Paczesny, S.
Oral Abstracts - Session I - GVH/GVL & Hematopoiesis/Mesenchymal Cells
Padmanabhan, A.
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Paff, Z.
Screening for Pulmonary Hypertension After Pediatric Hematopoietic Stem Cell Transplantation
Page, K.
Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
Pagel, J. M.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Novel Radioimmunotherapy Conditioning Prior to Stem Cell Transplantation in Patients with Lymphoma
Pai, A. L.
Adherence to the Outpatient Oral Medication Regime in Adolescent HSCT Recipients
Therapeutic Relationship Education On a Pediatric Bone Marrow Transplant and Immunology Unit
Pai, S. Y.
Gene Therapy for Primary Immune Deficiencies
Pai, V. B.
Efficacy of Low-Dose Acyclovir Prophylaxis Against Varicella Zoster Virus in Pediatric Hematopoietic Stem Cell Transplantation Patients
Pakakasama, S.
Novel Reduced Toxicity Conditioning Regimen for Older Severe Thalassemia Patients: Sequential Immunoablative Concept
Pal, J.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Palaniyandi, S.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Azithromycin Induces the Expansion of Regulatory T Cells and Diminishes Alloreactive T Cell Proliferation in Vitro and in Vivo
Palmer, J.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Palmer, J.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Palmer, J.
Clofarabine and High-Dose Melphalan As Reduced Intensity Conditioning in Adults with High-Risk Leukemia/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Pandit, A.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Pandya, C.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Panis, M. M.
Double Haploidentical Hematopoietic Stem Cell Transplantation Enhances Anti-Tumor Activity After Transplant
Pantin, J.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Papa-Rodriguez, T.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Papadopoulos, E.
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Papadopoulou, A.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Papanicolaou, G.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Incidence and Kinetics of CMV Infection After T-Cell Depleted and Unmodified Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience At Memorial Sloan-Kettering Cancer Center
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Papanicoleau, G. A.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Papermaster, A.
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Parameswaran, R.
Autologous Transplantation As Consolidation Therapy for Primary and Secondary CNS Lymphoma- A Single Center Experience
Park, C. W.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Park, J.
Evaluation of Pre-Transplant Risk Factors of Bacterial Bloodstream Infection (BSI) in Patients with Hematopoietic Stem Cell Transplantation (HSCT) and Comparison of BSI Between Allogenic and Autologous HSCT
Park, S. K. Sr.
The Effect of Sirolimus Based Regimen On Immune Reconstitution After Allogeneic Stem Cell Transplantation
Parker, P. M.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Parma, M.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Parmar, S.
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Parmar, S.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Cord Blood Storage for ≥ 5 Years Does Not Impact Engraftment
Parmentier, J.
Bridging the Silos: Utilizing the Lean Model Rapid Improvement Event to Improve the Mobilization Process
Parmentier, S.
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Parran, L.
Welcome and Introductions
DAY 2 Welcome and Introductions
Parsons, S. K.
(WC) Health Policy and Psychosocial Issues
Partlow, D.
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Pasquini, M. C.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Anatomy of a Study: Part Two
Anatomy of a Study: Part Two
BMT CTN 0702: Myeloma
BMT CTN 0702: Myeloma
Introduction to BMT CTN
Pasquini, R.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Patané, K.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Patel, A. N.
Updates on Stem Cell Use in Regenerative Medicine
Patel, H. S.
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Patel, M.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Patel, P.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Patel, P.
Sleep Interrupted: Nocturnal Care Disturbances
Patil, N. R.
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Patil, S.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Patnaik, M.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Patterson, A. E.
Clabsi Reduction: No Longer Just an Inpatient Initiative
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Paulson, K.
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Pavan, F.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Pavletic, S. Z.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
(WC) Autoimmune Diseases
Pawarode, A.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Peace, D.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Peace, P.
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Pearce, R.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Peccatori, I.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Pedamallu, C. S.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Pelaez, J. M.
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Peled, T.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Peltz, A.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Penack, O.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Penza, S.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Improved Survival of Patients (Pts) with Acute Graft-Versus-Host Disease (aGVHD) During Recent Years: Impact of Donor and Recipient Characteristics
Perales, M. A.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Delaying the Start of Triazole Prophylaxis 7 Days After Allogeneic HCT Does Not Affect Outcomes, Including Risk of Invasive Fungal Infection
Early Complications Post BMT
(WC) Graft Sources and Manipulation
Peralta-Hernandez, D.
Where Does Granulocyte Colony Stimulating Factor Use Stand Following Allogeneic Hematopoietic Stem Cell Transplant in 2012
Peres, E.
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Peres, E.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
Perez, L.
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Perez, M.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
Perez, W.
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Pergam, S. A.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis
Perkins, B.
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Perkins, J.
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Perko, R.
Elevated Gamma Delta T Cell Recovery Following Hematopoietic Stem Cell Transplantation Associated with Improved Long Term Overall Survival in Pediatric Patients with Acute Leukemia
Perloff, S.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Perry, A. M.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Perry, J.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Perseghin, P.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Peters, C.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Petersen, E.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Petersen, H.
Female Fertility After Allogeneic Stem Cell Transplantation in Denmark. A National Cohort Study
Petersen, S.
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Peterson, J.
Early Identification of HCT Patient Discharge Needs
Petros, W.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Petrovic, A.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies
Petz, L. D.
The Cure of HIV with Hematopoietic Cell Transplantation
Pfankuch, A. L.
The Ticking Clock, Time to First Antibiotic in a Highly Complex Pediatric Bone Marrow Transplant Ambulatory Setting
Pfizenmaier, K.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Pham, A.
Same Sibling Marrow Following Cord Allogeneic Transplantation As Therapy for Second Relapse APL: A Pediatric Case Report
Pham, A.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Phelps, M.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Phillip, C.
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
Phillips, D.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Phillips, J.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Phillips, K. S.
A Comprehensive Review of Dfci's Adult HSCT Data
Phillips, K.
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Phippard, D.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Pi, S.
Aberrant Expression of Myeloid Antigens Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia Patients with Short Survival
Pidala, J.
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
Regulatory T CELLS Specific for Minor Histocompatibility Antigens
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Cell Transplantation
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Pierson, N.
Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant
Pietryga, D. W.
Efficacy of Low-Dose Acyclovir Prophylaxis Against Varicella Zoster Virus in Pediatric Hematopoietic Stem Cell Transplantation Patients
Pillai, A.
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Pinxteren, J.
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
Pipkin, J. D.
Propylene Glycol-Free Melphalan May Induce Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation
PLAT, G.
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Platzbecker, U.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Podczervinski, S.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Podder, S.
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Poetschger, U.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Pogliani, E.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Poi, E.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Poi, M.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Poirier, L.
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Politikos, I.
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Polnett, A.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Pomales, J. M.
The Ticking Clock, Time to First Antibiotic in a Highly Complex Pediatric Bone Marrow Transplant Ambulatory Setting
Pon, D.
Hand-Foot Syndrome (HFS) in Hematopoietic Stem Cell Transplant (HSCT) Patients: Effect of Total Body Irradiation (TBI), Etoposide (VP16) and Palifermin
Ponce, D.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Poon, L.
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Popat, U.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Pope, B. D.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Pophali, P. A.
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Popplewell, L.
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Porat, I.
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
Porcher, R.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Porrata, L.
Redefining Engraftment Syndrome: The New Mayo Clinic Criteria
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Porteus, M.
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Portilla, C. A.
Post-Transplant Cyclophosphamide Is Feasible and Reduces Acute GvHD in Pediatric UCB Transplantation
Poston, A.
CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease
Pott, J. E.
Transitioning Nurse-to-Nurse Report to the Bedside
Pourpak, Z.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Power, S.
Gorillas in Our Midst
Preffer, F.
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Presler, C. M.
Supporting Siblings Through the Allogeneic Hematopoietic Cell Transplant Process: The Perspectives of Minor and Young Adult Siblings of Successful Transplant Recipients
Autologous Hematopoietic Cell Transplantation Can Prolong Life in High-Risk Neuroblastoma Patients in Partial Remission
Press, B.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Press, O. W.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Preussler, J. M.
Substantial Variation in Medicaid Coverage for Hematopoietic Cell Transplantation
Pring, J.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Prockop, S.
Epitopes of CMVpp65 Co-Presented by Multiple Allelic Variants of HLA Class-I Antigens: Implications for Adoptive Immunotherapy for CMV Using Third Party Donor –Derived CMV Specific CTLs
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Provost, M.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Puangsricharern, V.
Risk Factors for Dry Eye After Hematopoietic Stem Cell Transplantation
Puck, J.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Pulone, B.
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
Pulsipher, M. A.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Early and Late Medical Issues in Stem Cell Donation
Punzalan, R. C.
Autologous Stem Cell Collection for the Treatment of Malignant Diseases in Pediatric Patients: The Use of the Power Hickman
The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of Gvhd in Children
Purtill, D.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Puthenveetil, G.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders

Q

Qayed, M.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Qazilbash, M.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Qiu, H.
Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
Quigg, T. C.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Quigley, J.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Quinlan, D.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Quinn, G.
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Quinones, R.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Quintero, M.
Post-Transplant Cyclophosphamide Is Feasible and Reduces Acute GvHD in Pediatric UCB Transplantation

R

Rabiei, A.
Managing of Daily Improvement (MDI) Through Daily Huddles: Creating Culture and Engaged Problem Solving Nurse Coordinator Staff At City of Hope Department of Hematology & Hematopoietic Cell Transplant (HEM/HCT)
Racke, M.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Radford, K. W.
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Radhakrishnan, K.
Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of Agvhd
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Radhakrishnan, V. S.
Microbiology in Patients Undergoing Stem Cell Transplantation in the First Year of a Tertiary Care Comprehensive Cancer Centre From India
Radloff, G.
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Radocha, J.
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Ragucci, D.
Immune Reconstitution & Vaccine Response After Pediatric Allo-HSCT
Raguza-Lopez, M.
PI and Site Coordinator Protocol Adherence Panel
Raj, R.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Rajendran, J. G.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Rajkumar, S. V.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Ramakrishnan, S.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Ramanathan, M.
Autologous STEM CELL Transplant (ASCT) As an Effective POST-Remission Consolidation Strategy for Good Risk ACUTE Myeloid Leukemia (AML) Patients
Rambaldi, A.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Ramirez, N.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Ramirez, O.
Post-Transplant Cyclophosphamide Is Feasible and Reduces Acute GvHD in Pediatric UCB Transplantation
Ramos, C. A.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Randhawa, J. K.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Final Outcomes of Escalated Melphalan 280 MG/M2 Prior to Autologous Hematopoietic Cell Transplantation for Multiple Myeloma (MM) : High CR+VGPR Rate Does Not Translate Into Improved Survival
Rangarajan, H. G.
The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of Gvhd in Children
Rao, K. V.
Effectiveness of an Algorithm-Based Approach to Filgrastim-Based Mobilization Using Predetermined Decision Points for the Inclusion of Plerixafor
Utilization of an Algorithm for Chemomobilization Including the Use of Plerixafor in Poor Mobilizers
Rapoport, A.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Raptis, A.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Rasmussen, M.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Ratanatharathorn, V.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Ratnaparkhe, S.
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Raus, N.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Raval, M.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Ravandi, F.
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Rawas, A.
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Ray, R.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Development of Nurse Educator Role to Improve Nurse Education and Promote Nurse Retention
Ray, U.
Persistently High Gam Levels Are Associated with Nonrelapse Mortality in HCT Recipients Irrespective of Invasive Aspergillosis: A Prospective Cohort Study
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Raymond, G. V.
Approaches for Outcome Assessments: HCT for Metabolic Disease
Razzaghi, B.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Reardon, C. C.
Transplant Center Staffing Models for MLPs, RNs and Coordinators
Rebolledo, B. J.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Reburiano, E.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Reddy, P.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
Molecular Regulation of GVHD
Biology of GVH Responses: Recent Insights
Redondo Guijo, A.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
Reece, D. E.
Final Outcomes of Escalated Melphalan 280 MG/M2 Prior to Autologous Hematopoietic Cell Transplantation for Multiple Myeloma (MM) : High CR+VGPR Rate Does Not Translate Into Improved Survival
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Reeder, C.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Reeve, B. B.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Regier, M.
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Rehman, N.
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Reich, R. R.
Investigation of Community Respiratory Viruses in Hematopoietic Stem Cell Transplant Patients and Household Member Characteristics
Reichbach Douglas, J.
Can Intravesical Instillation of Recombinant Activated Factor VII (rFVIIa) and Aminocaproic Acid (AA) Stop Bleeding in Hemorrhagic Cystitis?
Reichle, A.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Remberger, M.
Fifteen Years' Experience of Home Care During the Pancytopenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation
Remick, S. C.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Ren, Y.
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Renbarger, J. L.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Renfroe, H.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Renner, R.
The Benefits of Metadata Analysis and Form Question Harmonization
Renteria, A. S.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Repaczki-Jones, R.
Panel Discussion
Requejo, A.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Restrepo, M.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Rettinger, E.
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Reu, F.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Rexer, P.
The Effect of Exercise Compliance in Patients Undergoing Hematopoietic Stem Cell Transplantation On Their Functional Capacity During Their Hospitalization
Rezaei, N.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Rezvani, K.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
The Role of Vaccination in Leukemia
Cancer Vaccines and T Cell Therapy in SCT
Rhollans, L.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Ribeira, J. M.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Ribeiro, A. F.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Ribeiro, L.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Ricci, A.
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Rich, E.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Richards, K.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Richardson, P. G.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Hepatic Veno-Occlusive Disease (VOD)/Sinusoidal Obstruction Syndrome (SOS) following HCT: Novel Insights to Pathogenesis, Current Status of Treatment and Future Directions
Riddell, S.
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Role of T Cell Subsets and CAR Design
Driving CARs to the Clinic
Ridges, R.
Ocular Chronic Gvhd: Increasing Opportunities for Impact and Awareness
Riggs, R.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Riley, J.
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Rimkus, C.
Bridging the Silos: Utilizing the Lean Model Rapid Improvement Event to Improve the Mobilization Process
Ringden, O.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Fifteen Years' Experience of Home Care During the Pancytopenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation
Rio, B.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Ritchie, D. S.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Ritsow, K. M.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Ritz, J.
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
Rivas, M.
Allogeneic Hematopoietic Stem Cell Transplant in Patients Older Than 50 Years. Experience of Four Argentinean Centers
Rivera, Z.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Rizzieri, D.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Rizzo, J. D.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
How Programs and Health Plans are Using Data to Improve Program Performance
CIBMTR Update
Robarge, J. D.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Roberts, C. H.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Roberts, S.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Robertson, J.
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Robey, N.
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Robins, H.
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Robison, A.
Utilizing QI Tools to Decrease Line Contaminiations
Rocha, V.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
How to Perform Cord Blood Transplantation
Oral Abstracts - Session A - Allogeneic Transplants
Welcome to the 2013 BMT Tandem Meetings
Rock, E. E.
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Roddy, J.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Roddy, R.
Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation
Rodela, T.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Rodrigues, M.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Rodriguez Calvillo, M.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Rodriguez, L.
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
Rodriguez, T. E.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Rodriguez, V.
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Roehrs, P. A.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Roepstorff, C.
Female Fertility After Allogeneic Stem Cell Transplantation in Denmark. A National Cohort Study
Rojas Porras, S.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
Röllig, C.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Rondelli, D.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Rondon, G.
Predicting Neutrophil Recovery by Changes in Serum Electrolyte Levels of Stem Cell Transplantation Patients
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Cord Blood Storage for ≥ 5 Years Does Not Impact Engraftment
Rooney, B.
NKG2D Ligands in Pediatric Cancer
Rooney, C. M.
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
BI-Specific T CELL Therapy for Pancreatic Cancer
Rosales, A. D.
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Rosati, C.
WHAT Tools ARE in Your Toolbox to Promote Change?
Rosen, L.
A Single Institution's Experience Utilizing Augmented CBV for Patients with Relapsed Diffuse Large Cell Lymphoma Undergoing Autologous Stem Cell Transplantation
Rosenblatt, H.
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Rosenblatt, J.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Rösler, W.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Rosmarin, A.
Autologous STEM CELL Transplant (ASCT) As an Effective POST-Remission Consolidation Strategy for Good Risk ACUTE Myeloid Leukemia (AML) Patients
Ross, G.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Ross, M.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Rosselet, R. M.
Chlorhexidine Gluconate Impregnated Waterless Bath System for the Reduction of Blood Stream Infections in the BMT Population
Rossetti, J.
Anti-Thymocyte Globulin At 6mg/Kg, Not 4.5mg/Kg, Protects From Severe Lethal Graft-Versus-Host Disease
Rotem-Yehudar, R.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Rothwell, A.
Oral Glutamine and Probiotics On Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Rotstein, C.
Micafungin Followed by Posaconazole Is Effective As Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation
Rovelli, A.
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Mesenchymal Stromal Cells: A Prospective, Multicentric, Phase 1 Study
Rowe, J.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Rowe, K.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Rowland, P.
Integrating Palliative/Supportive Care Concepts in the Blood and Marrow Transplant Setting
Rowley, D.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Rowley, S.
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Roy, D. C.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Roy, J.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Roy, V.
Effect of Body Mass Index On the Mobilizing Efficacy of Plerixafor in Patients Undergoing Autologous Stem Cell Collection: A Retrospective Study
Rozemuller, H.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Ruan, C.
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Rubin, E.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Rubinstein, P.
Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products
Rudolph, S.
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Ruebner, R.
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Ruehle, K.
A Culture of Continuous Quality Improvement Improves Registry Data
Cibmtr Data Management Training Survey 2012
A Culture of Continuous Quality Improvement Improves Registry Data
Ruggeri, A.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Ruiz-Arguelles, G. J.
Body Mass Index As an Indicator of Prognosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institution Experience
Ruiz-Argüelles, G. J.
In Pursuit of the Graft Versus Myeloma Effect: A Single Institution Experience
Ruiz-Delgado, G. J.
Body Mass Index As an Indicator of Prognosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institution Experience
In Pursuit of the Graft Versus Myeloma Effect: A Single Institution Experience
Ruppert, A. S.
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Russell, D.
Gorillas in Our Midst
Home Sweet Home: Our Experience Providing Immediate Post-Transplant Care to Patients in Their Home
Russell, J. A.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Ryan, J.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Ryan, R.
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Rybicki, L.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

S

Saad, C. Y.
Evaluating the Effect of High Dose Chemotherapy and Autologous Bone Marrow Transplantation (ASCT) On Hypertension (HTN) in Multiple Myeloma (MM) Patients
Sabatino, M.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Saber, W.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
The Emerging Role of HCT for Older MDS Patients
The Emerging Role of HCT for Older MDS Patients
Sabo, J. D.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Sabulski, A.
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Saccardi, R.
HCT for Severe Multiple Sclerosis
HCT for Non-Malignant Disorders
Sachs, D. H.
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
The MGH Miniature Swine As a Large Animal Model of HCT and Graft Versus Host Disease
Sadee, W.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Sahaf, B.
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Sahebi, F.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Sahovic, E.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Anti-Thymocyte Globulin At 6mg/Kg, Not 4.5mg/Kg, Protects From Severe Lethal Graft-Versus-Host Disease
Sainvil, M. M.
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Saito, N.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Sakai, R.
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Sakamaki, H.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Sakellari, I.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Sala, E.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Salem, G.
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Sales-Bonfim, C.
Challenges to Future Growth: The Transplant Center Perspective - Central/South America
Challenges to Future Growth: The Transplant Center Perspective - Central/South America
(WC) International Studies
Saliba, R.
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment
Salit, R.
Higher Infused CD34+ Dose Positively Influence Platelet Recovery After Cord Blood Transplantation
Salzman, D.
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Sams, K.
Clabsi Reduction: No Longer Just an Inpatient Initiative
Investigation of Community Respiratory Viruses in Hematopoietic Stem Cell Transplant Patients and Household Member Characteristics
Sanchez, A.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome
Sanchez Guijo, F.
The Use of 5-Azacitidine in Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience
Sanders, R.
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Sandfoss, E. L.
The Ticking Clock, Time to First Antibiotic in a Highly Complex Pediatric Bone Marrow Transplant Ambulatory Setting
Sandmaier, B. M.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Sandquist, S.
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Sankaranarayanan, N.
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Sanpakit, S.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Santos, F. P. D. S.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Santos, G. R.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Santos, T. N. Jr.
Evaluation of Antioxidant Enzyme Levels of Glutathione Peroxidase in Patients Undergoing A Autologous Hematopoietic STEM CELL
Santos, V.
A Paradigm Shift in Hematopoietic Progenitor CELL Apheresis: From Apheresis Technicians to Trained Oncology Nurses - Improving Patient Outcomes
Sanz, G.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Sanz, M. A.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Saps, M.
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Saraf, S.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Sarantopoulos, S.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Sarma, P.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Sarvaria, A.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Saslavsky, J.
Invasive Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results From a Single Center Retrospective Analysis
Satwani, P.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
Allogeneic Stem Cell Transplant for Children with Sickle Cell Disease Reduces Healthcare Utilization
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Saunders, P.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Sauter, C. S.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Sauvageau, G.
Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and IVIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
Nocardiosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Matched Case-Control Study of Risk Factors, Clinical Features and Outcomes
Pneumatosis Coli Associated to Severe Intestinal Graft Versus Host Disease Following Hematopoietic Cell Transplantation: Risk Factors and Dismal Outcome
Savani, B. N.
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Oral Abstracts - Session J - Late Effects/Quality of Life & Immune Reconstitution
Savoie, M. L.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Sayre, P.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Scaradavou, A.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Evaluation of Alternative Samples for Sterility Testing of HPC-CB Products
Vaccine Responses Following Unrelated Double Cord Blood Transplantation (CBT)
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Schaefer-Eckart, K.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Schaffer, W. L.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Schaich, M.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Schetelig, J.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Schickler, M.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Schlagenhauf, B.
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Schlatter, M.
Improving Reliability of Immunosuppressant Sampling Techniques
Schlesinger, S.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Schlis, K.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Schmid, D. S.
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Schmit-Pokorny, K.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
Schmitz, J.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Schmitz, N.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Schneider, D.
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Schneiderman, J.
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Schoenrock, K.
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Schrappe, M.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Schrauder, A.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Schrezenmeier, H.
Missing KIR-Ligands in Single Mismatched Unrelated Hematopoietic Stem Cell Transplantation
Schriber, J.
Transplant: The Ultimate Team Sport. A Potential Answer to Workforce Challenges in Hematopoietic Stem Cell Transplant
Schroeder, M. A.
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
Schrum, J.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Schultz, K. R.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
Schulz, A.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Schulz, G.
Incidence and Mechanism for Decreasing Central Catheter Contamination of Calcineurin Inhibitors in Stem Cell Transplant Patients Utilizing an Educational Intervention
Schuster, M. G.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Schweizer, J.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Scott, B. L.
The Impact of Mutational Analysis on Transplant Outcomes
The Emerging Importance of Mutational Analysis in MDS/AML
Scott, E. C.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Seber, A.
Timely Capture of Relevant Data for Cibmtr
The Cost of Pediatric Unrelated HSCT
(WC) Pediatric Cancer
Sekeres, M.
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Sekine, R.
High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis –Single Institute Analysis of 35 Cases–
Sekine, T.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Selby, G.
Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Retrospective Analysis of Intravenous DMSO Toxicity in Transplant Patients
Selby, G.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Sell, M.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Selvakumar, A.
Epitopes of CMVpp65 Co-Presented by Multiple Allelic Variants of HLA Class-I Antigens: Implications for Adoptive Immunotherapy for CMV Using Third Party Donor –Derived CMV Specific CTLs
Senapati, S.
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Sender, L.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Development of a Consistent Approach to the Management Chemo/Radiation Induced Dermatitis in Children Undergoing Allogeneic Stem Cell Transplantation
Sengelov, H.
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Sengeløv, H.
Female Fertility After Allogeneic Stem Cell Transplantation in Denmark. A National Cohort Study
Senitzer, D.
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Senner, A. M.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Seo, S.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Seo, S. K.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Serafino, S.
Decreasing Readmission Rates in Autologous Stem Cell Transplant Patient for Symptom Management
Serody, J. S.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Seroogy, C.
Diagnostic and Treatment Dilemmas From Statewide Newborn Screening for Severe Combined Immunodeficiency
Seropian, S.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Serve, H.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Setterholm, M.
Young Male Donors Provide the Best Chance of Meeting Requested Cell Dose for PBSC and Bone Marrow Transplantation
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
How Much Is Enough? Ethical Consideration for the Depletion of Large Public Cord Blood Units (CBU)
Setubal, D. C.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Shah, J.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Shah, J.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Shah, N.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Fluid Retention and Weight Gain During Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis
Autologous Hematopoietic Stem Cell Transplantation in Light Chain Amyloidosis (AL) with Renal Involvement
Shah, N.
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Oral Abstracts - Session H - Pediatric Disorders & GVH/GVL
Shahin, K.
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Shaim, H.
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Shamshiri, A.
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Shamsian, B.
Primary Hemophagocytic Lymphohistiocytosis and Hematopoeitic Stem Cell Transplantation in Iran
Shanley, R.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Shapiro, J.
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Sharf, A.
Autologous Hematopoietic Cell Transplantation Can Prolong Life in High-Risk Neuroblastoma Patients in Partial Remission
Sharf, S. E.
Improving Patient Satisfaction in the Outpatient BMT Clinic Setting
Quantifying Resource Needs beyond Transplant
Sharma, M.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Sharma, P.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Shatten, C.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Shaughnessy, P. J.
Influence of Diabetes On Autologous Hematopoietic Stem Cell Mobilization
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome
Sub-Therapeutic Levels of ORAL Tacrolimus Prophylaxis PRIOR to Allogeneic STEM CELL Transplant Do NOT Predict the Incidence of Chronic GRAFT Versus HOST Disease
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Shaw, B.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Significantly Higher Rates of Donor Attrition in Minority Ethnic, Female and Older Donors: A Review of 7542 Confirmatory Typing Requests at Anthony Nolan
Oral Abstracts - Session N - Allogeneic Transplants & Histocompatibility
Shayani, S.
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Shea, T. C.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Effectiveness of an Algorithm-Based Approach to Filgrastim-Based Mobilization Using Predetermined Decision Points for the Inclusion of Plerixafor
Utilization of an Algorithm for Chemomobilization Including the Use of Plerixafor in Poor Mobilizers
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Transplantation and Maintenance Strategies for DLBCL
Controversies in BMT for High Grade Lymphoma
Shearer, W.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Shelhamer, J. H.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Shelton, B.
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Shem-Tov, N.
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients with Chemo-Sensitive Disease and with Treosulfan-Based Conditioning
Shenoy, S.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Neurocognitive Function in Pediatric Stem Cell Transplant Recipients Following Low Dose Single Fraction Total Body Radiation and Cyclophosphamide
Incidence and Mechanism for Decreasing Central Catheter Contamination of Calcineurin Inhibitors in Stem Cell Transplant Patients Utilizing an Educational Intervention
(WC) Non-Malignant Marrow Disorders
Shenvi, S.
Glutathione Redox Metabolomic Dysregulation Precedes TNF-α Elevation and Predicts Severity of Gvhd in Experimental Transplantation
Shereck, E.
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Sherwood, A.
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Shields, A.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Shimamura, A.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Shimoji, S.
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Shimoni, A.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients with Chemo-Sensitive Disease and with Treosulfan-Based Conditioning
Shimono, N.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Shin, C. R.
Diagnostic and Treatment Dilemmas From Statewide Newborn Screening for Severe Combined Immunodeficiency
Shin, S. H.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Shinagawa, K.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Shizuru, J. A.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Shlomchik, W. D.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Mechanisms of GVL and GVL-Resistance
Shoham, H.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Shono, Y.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Shono, Y.
T Cell Immunotherapy Enabled by Imaging-Guided Injections of Lymphoid Organs
Shook, D.
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Shook, T.
Standardizing Standard Operating Procedures' (SOP) Manual to Benchmark Cell Processing Laboratory (CPL) Performance
Shore, T.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Short, C.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Short, L.
Commitment to an Intergrated Health Model
Shpall, E. J.
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Cord Blood Storage for ≥ 5 Years Does Not Impact Engraftment
Cord Blood Stem/Progenitor Cell Expansion to Enhance Engraftment
Oral Abstracts - Session D - Allogeneic Transplants
Sid-Otmane, L.
Therapeutic Drug Monitoring (TDM) of Cyclosporine Using the Area Under the Curve in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Siddiqui, M.
Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)
Sideroff, M.
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Siegel, D.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Siemionow, M.
Human Di-Chimeric Cells a New Approach for Tolerance Inducing Protocols in Transplantation: A Preliminary Study
Sierra, J.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Sigua, C. L.
Research Qpcr Method for Engraftment Monitoring: A 6-Year Review of Proficiency Testing Results
Platform Independent Multiplex qPCR Research Assay for Chimerism Analysis
Siler, D.
Standardizing Education and Competencies Across A Network
Silliman, C. C.
Pediatric Post Transplant Neutrophil Function
Silverman, L. B.
The Role of Transplant in Infant ALL
Simpkins, P.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Simpson, A.
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Sub-Therapeutic Levels of ORAL Tacrolimus Prophylaxis PRIOR to Allogeneic STEM CELL Transplant Do NOT Predict the Incidence of Chronic GRAFT Versus HOST Disease
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Sinamura, L. A. Jr.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Singer, N. V.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Singh, H.
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Singh, J.
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Sinha, R.
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Sirop, S. J.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Sito, E.
Importance of Preceptor Competency and Its Role in Orientee Satisfaction and Retention
Sizemore, C.
Maintenance Hypomethylating Therapy Post Allogeneic Stem Cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous Leukemia or Non Responsive Myelodysplastic Syndrome
Skaar, T. C.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Skeens, M.
Impact of Specialty Nursing Model On Pediatric Bone Marrow Transplant Patient Outcomes
Vitamin D Status and Its Correlation with Bone Mineral Density in Long Term Survivors After Childhood Hematopoietic Stem Cell Transplantation
Immunogenecity of Early Post Transplant Vaccination in Children
Skinner, R.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Sklyar, T.
BK Virus by PCR From Peripheral Blood At Day 21 After Allogeneic Transplant Predicts Risk for Hemorrhagic Cystitis
Skoda-Smith, S.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Slack, J.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Slaper-Cortenbach, I.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Slater, S.
Predictive Classification of Chronic Gvhd Status by Immune Reconstitution Testing
Chronic Gvhd-Associated Serositis and Pericarditis
Slatter, M.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Small, B.
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Small, T.
Vaccine Responses Following Unrelated Double Cord Blood Transplantation (CBT)
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Smeltzer, J.
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Smethurst, D.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Smiley, K.
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Smith, A.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Smith, C.
Towards the Development of a Closed, Nanofiber-Based Culture System for Clinical Expansion of Cord Blood CD34+ Cells
Smith, C. C.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Smith, G. M.
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Smith, J.
Alcohol Impregnated Caps: Are They Effective for Preventing Clabsi?
Smith, K.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Smith, O. M.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Smith, R.
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Smith, S. M.
Non-transplant Therapies for Mantle Cell Lymphoma and TCL
Smith, S.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Smith, T.
Plasma Cell CD20 Expression: Primary Aberrant Expression or Receptor up-Regulation
The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Leukocytosis Post Engraftment Is Associated with Increased Mortality Among Adult Allogeneic Hematopoietic Cell Transplant (HCT) Reciepients
Smolik, S.
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Snider, V.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Snyder, D.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Sobecks, R.
Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
Risk Factors for Prolonged Length of Hospitalization in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Sobrinho, J. J. N.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Socié, G.
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Sodha, A.
Towards the Development of a Closed, Nanofiber-Based Culture System for Clinical Expansion of Cord Blood CD34+ Cells
Soerensen, J.
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Soiffer, R. J.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
CD25+ Regulatory T CELL-Depleted DONOR Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study
Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling
Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Reducing Inappropriate Testing Following NCCN and IDSA Guidelines in Autologous Stem Cell Transplant (SCT) Patients
Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2)
A Retrospective Review Comparing Outcomes of Patients Receiving Reinduction Therapy On House Staff and PA Services
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Sola, C.
Hematopoietic STEM CELL Transplantation in Myelofibrosis: A Comparison Between Myeloablative and Reduced Intensity Conditioning
Solano, C.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Solh, M.
Plasma Cell CD20 Expression: Primary Aberrant Expression or Receptor up-Regulation
The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Leukocytosis Post Engraftment Is Associated with Increased Mortality Among Adult Allogeneic Hematopoietic Cell Transplant (HCT) Reciepients
Solomon, S. R.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Maintenance Hypomethylating Therapy Post Allogeneic Stem Cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous Leukemia or Non Responsive Myelodysplastic Syndrome
Soma, T.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Somaiya, P.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Somech, R.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Son, T.
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Song, X. T.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Soni, A.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Soni, S.
Immunogenecity of Early Post Transplant Vaccination in Children
Sonnenday, C.
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Sorensen, S.
The Benefits of Metadata Analysis and Form Question Harmonization
Soriano, G.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Sorror, M. L.
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
(WC) Late Effects and Quality of Life
Sotiropoulos, D.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Souza, M. P. D.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Sowell, H.
Hematopoietic CELL Transplantation (HCT)-Specific Comorbidity INDEX in Autologous STEM CELL Transplant Indicates People with Advanced Age and Increased Comorbidity INDEX Should BE Hosptialized Through Engraftment
Implementing an Evidence-Based Protocol for the Management of Neutropenic Patients in the Emergency Department
Spear, D.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Spellman, S. R.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
A Practical Approach to Reporting HLA Typing to CIBMTR
Oral Abstracts - Session N - Allogeneic Transplants & Histocompatibility
Sper, C.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Spiegel, C.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Spiegel, I.
A Novel Process Technology for Automated NK Cell Culture and Enrichment
Spielberger, R.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Spierings, E.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Spitzer, T. R.
Outcomes of Patients Older than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Stem Cell Transplantation for MDS/AML
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Immune Modulation of Antibody Responses Induced Through Allogeneic Cell Transplantation
The MGH Miniature Swine As a Large Animal Model of HCT and Graft Versus Host Disease
Sportes, C.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Sproat, L. O.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Outcomes of Hematopoietic Cell Transplantation in Ethnic and Racial Minorities
Sprouse, D.
Enhancing Nursing Practice and the Patient Experience in the BMT Program Using the Principles of Patient– and Family-Centered Care
Spychala, M.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Srinivasan, A.
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Srivastava, A.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
Challenges to Future Growth: The Transplant Center Perspective - Asia-Pacific
Challenges to Future Growth: The Transplant Center Perspective - Asia-Pacific
Challenges to Future Growth: The Transplant Center Perspective - Asia-Pacific
Srivastava, D. K.
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Stachel, K. D.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Stadtmauer, E. A.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
PI and Site Coordinator Protocol Adherence Panel
(WC) Solid Tumors
Stainthorpe, M.
Sleep Interrupted: Nocturnal Care Disturbances
Stasko, K.
Implementing Novel Predictive Parameters in Apheresis
Staton, S.
Improvement in Early Recognition of Deteriorating Pediatric Bone Marrow Transplant Patients
Stednick, Z.
Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients
Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients
Steffens, G.
Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate
Steinberg, A.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Steinberg, S.
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Steinert, P.
KGF Update
Steingart, R. M.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Stelljes, M.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Stempora, L.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Stentz, A.
HDM/ SCT for AL Amyloidosis - a Single Institution 12 Year Experience
Stevens, A.
The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis
Steward, J.
The Impact of Comorbidity, Performance Status and Insurance Coverage in Patients Undergoing Myeloablative Allogeneic Transplant
Stewart, D.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Stewart, S.
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Stiff, P. J.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Stiller, T.
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Stillwell, E. E.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Stites, J.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Stockerl-Goldstein, K.
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
Stokes, J.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Stokes, K. Y.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Stone, R.
A Retrospective Review Comparing Outcomes of Patients Receiving Reinduction Therapy On House Staff and PA Services
Storb, R. F.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
GVHD, Graft-vs-Tumor Effects, and Mortality After Allogeneic Transplantation
Storek, J.
Different Natural Killer (NK) Cell Subsets Elicit Unique Target Induced Immune Responses: Implications for Assessment of Posttransplant Functional Recovery of the Relevant NK Cell Subsets and Their Impact On HCT Outcomes
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Storer, B.
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Response Endpoints for Acute Graft-Versus-Host Disease Treatment Trials
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Stoudemire, T.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Strahm, B.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Stringaris, K.
Stem-Like Characteristics in a Subset of CD161 Expressing Human Memory CD4+ T Cells Facilitates Their Survival After Chemotherapy
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Strober, S.
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Strobert, E.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Stroncek, D. F.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
(WC) Donor Health and Safety
Strullu, M.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Stryhn, A.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Stuart, R.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Stubbs, J. R.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Stuhler, G.
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Sturtevant, O.
Implementing Novel Predictive Parameters in Apheresis
Stuth, J.
Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate
Stuve, O.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Su, J.
Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
Sugawara, E. K.
Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
Sugrue, M.
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Suh, J.
Glutathione Redox Metabolomic Dysregulation Precedes TNF-α Elevation and Predicts Severity of Gvhd in Experimental Transplantation
Sui, D.
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Sullivan, K.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Sumaili, T.
Treatment of High-Risk Pre-B Acute Lymphoblastic Leukemia in a Fanconi Anemia Patient with Reduced-Intensity Chemotherapy
Sun, A.
Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Sun, C.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Sun, Y.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
Sun, Y.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Sun, Y. Q.
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Sung, A. D.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Sung, J. A. M.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Superata, J.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Sutton, M.
Standardizing Education and Competencies Across A Network
Suzuki, K.
High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis –Single Institute Analysis of 35 Cases–
Suzuki, R.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Svahn, B. M.
Fifteen Years' Experience of Home Care During the Pancytopenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation
Sweiss, K.
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Switzer, G. E.
Psychosocial Issues in Stem Cell Donation
Switzer, K.
CD19-Specific T Cells Developed to Persist When Antigen Load Is Low: Implications for Treating Minimal Residual Disease After Hematopoietic Stem-Cell Transplantation
Sykora, K. W.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Sylvanus, T.
Blood and Marrow Transplant Outreach Presentation Promoting BMT Nursing as a Career Choice: Pre and Post Survey Results
Symons, H. J.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Pediatric Patients with High Risk Hematologic Malignanices
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Syrjala, K. L.
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Szabolcs, P.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
IL-15 Alone Supports in Vitro Generation of Polyclonal CTL From CD3/CD28 Co-Stimulated Expanded CB T Cells Against Leukemia Cells
(WC) Infection and Immune Reconstitution
Szer, J.
High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
Oral Abstracts - Session B - Lymphoma/Multiple Myeloma & Autologous Transplants
Szymanski, G.
In-Patient-Out-Patient Program (IPOP) Care Continuum at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital
Szymanski, S.
Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome

T

Tackett, K.
A Randomized Study to Compare the Effect of 2-Hour and 6-Hour Schedules of Cryotherapy On the Incidence of Severe Mucositis in High Dose Melphalan
Takahashi, S.
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Takami, A.
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Takashima, S.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Takatsuka, Y.
Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Takenaka, K.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Takeuchi, S.
Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Talano, J. A.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of Gvhd in Children
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Talpaz, M.
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Tamaki, H.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Tamari, R.
High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse
Tamburro, R.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Tan, A. M.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Tan, P. L.
HLA Allele Matched Unrelated Donor Stem Cell Transplant As First Line Therapy for Children with Acquired Severe Aplastic Anemia
Tanaka, J.
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Tang, F. F.
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Taniguchi, K.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Taniguchi, S.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Taniguchi, Y.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Tanimoto, K.
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Tanimoto, K.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Tanimoto, M.
Contribution of the PD–1–PD–L Pathway to Chronic Graft–Versus–Host Disease
Tarin, R.
Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Tassara, M.
Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience At San Raffaele Scientific Institute
Tauro, M.
Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
Tauscher, C.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Tavares, R.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Tawara, I.
Targeting Deacetylases As a Novel Strategy for Prevention of Acute Gvhd
Tayebi, S.
Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia Based On Conditioning Regimen without Total Body Irradiation
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Taylor, A.
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Taylor, C.
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Taylor, K. J.
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Taylor Smith, L.
Same Sibling Marrow Following Cord Allogeneic Transplantation As Therapy for Second Relapse APL: A Pediatric Case Report
TBD, T.
Bloodstream Infections
Nursing Competencies
Palliative Care and HCT
Vaccinations
Survivorship
Tool Box
Readmission Rates
In Home Transplant Care/Discharge
Mobilization
Falls
te Boome, L.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Tekgunduz, E.
BEAM or ICE?
Tench, S.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Terjimanian, M.
The Impact of Sarcopenia On Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma
Terwey, T.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease
Teshima, T.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Tetik, A.
BEAM or ICE?
Teusink, A.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Improving the Management of Hypertension in Pediatric Hematopoietic Stem Cell Transplantation
Thacker, D. L.
Indoleamine 2,3-Dioxygenase (IDO) Activity Is Associated with Acute Graft-Versus-Host Disease (GVHD) in Human Allogeneic HSCT
Thall, P.
Dose Intensification of Busulfan in the Preparative Regimen Is Associated with Improved Outcomes: A Phase I/II Controlled, Randomized Study
Therrien, R.
Therapeutic Drug Monitoring (TDM) of Cyclosporine Using the Area Under the Curve in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Thiede, C.
Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
Thielbeer, R.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Thoburn, C.
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Thoma, M.
Allograft Leukocyte Content and Post-Allogeneic Hematopoietic Cell Transplant Lymphopenia and Monocytopenia
Thomas, M.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Thomas, P.
Elevated Gamma Delta T Cell Recovery Following Hematopoietic Stem Cell Transplantation Associated with Improved Long Term Overall Survival in Pediatric Patients with Acute Leukemia
Thomas, S.
Clofarabine and High-Dose Melphalan As Reduced Intensity Conditioning in Adults with High-Risk Leukemia/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
Influence of Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Variants On Sirolimus Blood Levels in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Thomas, S. V. M.
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
Thompson, A. L.
Factors Impacting Family Decisions to Pursue Transplantation for Children with Sickle Cell Disease
Thompson, C. A.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Thompson, J.
New AdvantageEDC Forms: Infection Form/GVHD Form
Thompson, J.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Thornton, R. H.
T Cell Immunotherapy Enabled by Imaging-Guided Injections of Lymphoid Organs
Tiao, G. M.
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
Tibes, R.
Usefulness of 3 Monthly Marrow Evaluations in Predicting Relapse of Myeloid Malignancies After HCT
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Tierney, D. K.
Using Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) to Predict Autologous Transplant-Related Toxicities in Elderly Patients Aged 65 or Older
Tiffani, T.
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Tilearcio, M. C.
A Comprehensive Review of Dfci's Adult HSCT Data
Tindle, S.
Pretransplant Psychiatric Evaluations - a Survey of NMDP Programs
Tiwari, D.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Tkachev, V.
Allogeneic T Cells up-Regulate Fatty Acid Metabolism and Can Be Targeted Through Metabolic Inhibition of Fatty Acid Oxidation
Tokunaga, M.
Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Tolar, J.
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Tombleson, R.
Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Tomblyn, M.
Outcomes of Allogeneic HSCT for Patients with Hematologic Malignancies (AML, ALL, MDS, CML) with and without Pre-Existing Fungal Infections: A Cibmtr Study
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)
Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
Development of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Assessment of a Disease Risk Index in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Fludarabine and Pharmacokinetically Dose-Targeted Intravenous Busulfan: Effect On Overall and Progression-Free Survival
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
Molecular Markers
Molecular Markers
Introduction to CIBMTR
Tomchuck, S. L.
Isolation, Expansion & Function of Cord Blood Natural Killer Cells
Tomczak, N.
Individualized Care Planning Process
Tompkins, C.
Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Tonon, J. A.
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Toor, A. A.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Torgerson, T.
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Torno, L.
Successful Autologous Cord Blood Transplantation in a Child with Acquired Severe Aplastic Anemia
Tolerability of Daily Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation for Non-Malignant Disorders
Toro, A.
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Toro, J. J.
Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?
Toro, J. J.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Touma, W.
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
Tourel, J.
Therapeutic Drug Monitoring (TDM) of Cyclosporine Using the Area Under the Curve in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Tran, S.
Use of National Registry Demographic Data for Resource Planning
Treister, N.
Oral Complications
Tricot, G. J.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Trifilio, S.
Polymicrobial and Multiple Microbiologically Proven Infections in HSCT Recipients
Triplett, B. M.
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Haploidentical Donor Transplantations with TLI, Fludarabine, Cyclophosphamide, and ATG Are Safe and Effective Treatment for Graft Failure
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Trivedi, J. S.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Trumpfheller, C.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Truong, Q.
Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation
Tsai, J. J.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Tsai, N. C.
Clofarabine and High-Dose Melphalan As Reduced Intensity Conditioning in Adults with High-Risk Leukemia/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
Tse, W.
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Tse, W. T.
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Tsuchihashi, R.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Tsuji, M.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Tsukada, N.
High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis –Single Institute Analysis of 35 Cases–
Tuckett, A. Z.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
In Vivo Generation of Thymus-Independent T Cells in a Tissue-Engineered T Cell Development Supporting Microenvironment
T Cell Immunotherapy Enabled by Imaging-Guided Injections of Lymphoid Organs
Tucunduva, L.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Turner, R.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Turtle, C.
Depletion of Naïve T Cells From Peripheral Blood Stem Cell Grafts for Gvhd Prevention
Twohy, E.
Factors Impacting Family Decisions to Pursue Transplantation for Children with Sickle Cell Disease
Tyler, E. M.
CT7/MAGE-C1 Expression and Immune Responses Following Allogeneic Transplant for Multiple Myeloma

U

Uberti, J.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Uchida, N.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Ueki, S.
Risk Analysis of Falls in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Ueno, H.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Ugur, B.
BEAM or ICE?
Uhl, L.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Urata, S.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Urban, A.
Multi-Center Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in Reccurrent or High Risk Plasma Cell Myeloma
Urbano Ispizua, A.
(WC) Graft-versus-Host Disease
Urbano-Ispizua, A.
Oral Abstracts - Session B - Lymphoma/Multiple Myeloma & Autologous Transplants
Uryu, H.
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Ustun, C.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Utsnomiya, A.
Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Uzunel, M.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

V

Vadakara, J.
Single Institution Review of Allogeneic Bone Marrow Transplantation for Multiple Myeloma: An 18 Year Experience
Vajdic, C.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Valcarcel, D.
Evaluation of Transjugular Liver Biopsy in the Diagnosis of Early Hepatic Dysfunction After Allogeneic Hematopoietic Cell Transplantation
Valdés-Burnes, S. L. Jr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Valdez, B.
The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Valla, K.
Debate: Busulfan - To PK or Not to PK - Clinical Impact
van de Ven, C.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
van den Brink, M. R. M.
In Vivo Generation of Thymus-Independent T Cells in a Tissue-Engineered T Cell Development Supporting Microenvironment
T Cell Immunotherapy Enabled by Imaging-Guided Injections of Lymphoid Organs
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Improving Thymic Recovery
van den Brink*, M. R. M.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
van der Wagen, L.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
van Halteren, A.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Van Houwelingen, H. C.
Landmark Analysis and Dynamic Prediction Models
Van Meter, E.
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
van Tol, M.
Biopsies ARE Essential During Monitoring of Response to Mesenchymal Stromal CELL Therapy in Children with Gastrointestinal ACUTE GRAFT Versus HOST Disease
Van't Hof, W.
Dissection of the Human Multipotent Adult Progenitor Cell (MAPC) Secretome by Proteomic Analysis
Vanak, J. M.
Establishing a Post-Hematopoietic Stem Cell Transplant Immunization Clinic: A Single Institution Experience
Vander Lugt, M.
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Varda-Bloom, N.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Vase, T.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Vasir, D.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Vasu, S.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Impact of Atorvastatin On Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)
Vaughan, W.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
A Restrictive Red Cell Transfusion Approach Does Not Adversely Affect Day 100 or 1 Year Survival in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Vazquez, E. R.
Retrospective Data Review of Blood and Marrow Transplant (BMT) Medicare Coding to Analyze Coverage and Reimbursement Claims
Veerapathran, A.
Regulatory T CELLS Specific for Minor Histocompatibility Antigens
Vega, J.
Clabsi Reduction: No Longer Just an Inpatient Initiative
Velasquez, A.
Palliative Care Intergration Into an Acute Leukemia and Bone Marrow Transplant Program
Veltri, L.
Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation
Incidence and Pattern of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Non-Myeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
Venkataramanan, R.
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Venniyil Radhakrishnan, S.
Reactivation of Murine Cytomegalovirus Is Associated with Increased Gvhd Severity in Allogeneic Hematopoietic Cell Transplant Recipients
Azithromycin Induces the Expansion of Regulatory T Cells and Diminishes Alloreactive T Cell Proliferation in Vitro and in Vivo
Venstrom, J. M.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Venton, G.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Venugopal, P.
Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
Impact of CD 34 Cell Dose and Conditioning Regimens On Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
Vera, J. F.
A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
BI-Specific T CELL Therapy for Pancreatic Cancer
Vergueiro, C.
The Cost of Pediatric Unrelated HSCT
Verma, N. D.
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
Verneris, M. R.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Vesole, D.
Final Outcomes of Escalated Melphalan 280 MG/M2 Prior to Autologous Hematopoietic Cell Transplantation for Multiple Myeloma (MM) : High CR+VGPR Rate Does Not Translate Into Improved Survival
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Vey, N.
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (allo) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience
Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Veys, P.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
(WC) Immune Deficiencies/Inborn Errors
Viers, K.
Connecting Quality Reporting to Dashboards and Benchmarks
Vigorito, A.
Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations
Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population
Vij, R.
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
Villa, M.
Polymicrobial and Multiple Microbiologically Proven Infections in HSCT Recipients
Standardizing Standard Operating Procedures' (SOP) Manual to Benchmark Cell Processing Laboratory (CPL) Performance
Villamin, C.
Individualized Care Planning Process
Villanueva, J.
Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Villarreal-Martinez, L. Jr.
“Another Method for Thawing Hematopoietic STEM CELLS and Its Impact in the Recovery of the Transplanted Hematological Patient
Vindeloev, L.
Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients
Vindeløv, L.
Identification of Y-Chromosomally Encoded Minor Histocompatibility Antigens Using a Reverse Immunology Approach
Vindelov, L. L.
Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2
Vinks, A.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Violago, L.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
Visscher, M. O.
Novel Strategy for Non-Invasive Sampling of Epidermal Cytokines Using a Skin Sampling Disc in Acute Skin Graft Versus Host Disease and Engraftment Syndrome
Viswabandya, A.
Clinical Profile and Outcomes of Patients with â Thalassemia Major and Hepatitis C Virus Infection Undergoing an Allogeneic Stem Cell Transplant
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
POST-Transplant Cyclophosphamide (PTC) As Sole GRAFT Versus HOST Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling DONOR STEM CELL Transplant (SCT) for Severe Aplastic Anemia (SAA)
Vitale, K.
Impact of Palifermin On Incidence of Mucositis and Length of Hospitalization in Children Undergoing Autologous Hematopoietic Stem-Cell Transplant for Malignant Disorders
Voelkel, G.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Vogl, D.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Volchek, Y.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients with Chemo-Sensitive Disease and with Treosulfan-Based Conditioning
Volt, F.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
von Stackelberg, A.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Vose, J. M.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Vu, T.
Examining the Evidence for Frequency of Vital Sign Monitoring During Transfusion of Blood Products in the Stem Cell Transplant Patient Population
Vuong, L.
Long-Term Remission After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Active Disease

W

Wachowiak, J.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Wacker, K.
Practices for Complying with FACT Standards and Navigating New Editions
Panel Discussion
Wadia, P. P.
Platform Independent Multiplex qPCR Research Assay for Chimerism Analysis
Identification and Typing of Killer-Cell Immunoglobulin-Like Receptors (KIRs) Using Quantitative PCR Assay Reagents for Research
Waghmare, A.
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Wagner, J. E.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Hematopoietic Cell Transplantation for Acute Leukemia and Advanced Myelodysplastic Syndrome in Fanconi Anemia
Bone Marrow is the Preferred Graft for Allogeneic Hematopoietic Cell Transplantation in Severe Epidermolysis Bullosa
Wagner, J. L.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC)
Wagoner, J.
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
Wahlstrom, J. T.
Recovery of Lymphocyte Function May Predict Risk of Leukemic Relapse in Pediatric Patients Undergoing Allogeneic Stem Cell Transplant
Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies
Walker, B. J.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Walko, C. M.
Debate: Busulfan - To PK or Not to PK - Clinical Impact
Wall, D. A.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated On Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Wallace, G.
Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Eight Years Single Center Experience
Wallace, M. H.
Transforming Change of Shift Handoff: Implementing Walking Rounds in Adult Bone Marrow Transplant
Wallace, P.
Forms Completion Understanding CRF/TED
Waller, E. K.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
A First-in-Disease Trial of in Vivo Costimulation Blockade for GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD
Walsh, W.
Autologous STEM CELL Transplant (ASCT) As an Effective POST-Remission Consolidation Strategy for Good Risk ACUTE Myeloid Leukemia (AML) Patients
Walter, M. J.
Splicing Factor Mutations and Clonal Evolution of MDS
Walter, R. B.
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Walters, K.
Staffing Models
Walters, M.
Glutathione Redox Metabolomic Dysregulation Precedes TNF-α Elevation and Predicts Severity of Gvhd in Experimental Transplantation
Wang, C.
NKG2D Ligands in Pediatric Cancer
Changing Epidemiology of Infections in Children and Adolescents After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Wang, D.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Wang, E.
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis
Wang, F. R.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Wang, G.
The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan
Mechanistic Studies of the Synergistic Cytotoxicity of Clofarabine and Gemcitabine in Multiple Myeloma Cell Lines: Relevance of p53-Status
Wang, H.
Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD)
Wang, H.
In Vivo Generation of Thymus-Independent T Cells in a Tissue-Engineered T Cell Development Supporting Microenvironment
Wang, H.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Wang, J.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Wang, J. Z.
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Wang, L.
In Vivo Generation of Thymus-Independent T Cells in a Tissue-Engineered T Cell Development Supporting Microenvironment
Wang, L.
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Wang, M.
High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis
Wang, S. A.
Mixed Phenotype Acute Leukemia: Patient Outcomes According to the WHO 2008 Classification
Wang, Y.
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Wang, Z.
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Waqar, A. N.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Ward, V.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Warkentin, P. I.
Panel Discussion
Warlick, E.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Warren, E. H.
Evolution and Clinical Implications of the T Cell Repertoire Following Cord Blood Transplant
Laboratory Correlates of Immune Reconstitution At 1-Year Following Related, Unrelated, and Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Correlation with Survival
Watkins, B.
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Watkins, K.
A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies
Wayne, A. S.
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Wease, S.
Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Wease, MPH, S.
Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
Weber, C.
Description of Adverse Drug Events Associated with High-Dose Undiluted Etoposide (VP-16) Among Hematopoietic Stem Cell Transplant Recipients
Wehrlen, L.
Loneliness in Transplant Caregivers: Exploration of Related Factors
Wei, L.
Autologous Hematopoietic Stem Cell Transplant (aHSCT) Is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
Weinberg, K. I.
Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Weisdorf, D. J.
Similar Survival in Patients with Acute Myeloid Leukemia Relapsing after Matched Related Donor and Umbilical Cord Blood Transplantation
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD)
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic Gvhd
Utility of Grip Strength and 2 Minute Walk Test in Chronic Gvhd Assessment: An Analysis From the Chronic Gvhd Consortium
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
AML after 60: Talking 'Bout My Generation
Treatment for Acute GVHD
Has MRD Monitoring Superseded Other Prognostic Factors in Adult ALL?
BMT Tandem Breakfast Symposium: The Significance of Minimal Residual Disease in Adult ALL
Weisenburger, D.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Weiss, B.
Autologous aGVHD Associated with Infusion of T-Cells with Engineered Specificity for NY-ESO-1 and Lage-1 Following High-Dose Melphalan and ASCT in Patients with Multiple Myeloma
Weiss, M.
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes
Wells, D.
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Weng, W. K.
TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Wermers, R.
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Wessler, J. D.
Stress Testing Prior to Allogeneic Hematopoietic Stem Cell Transplantation
West, D.
Clinical Features of Acute Cutaneous Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
West, M. L.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Westervelt, P.
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
Westgren, M.
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Weyl-Ben-Arush, M.
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
White, D. J.
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
White, E.
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Biomarkers of Extracellular Matrix Remodeling in Chronic Gvhd
Whitley, J.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Wilbur, D. S.
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Wilcox, L.
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Use of National Registry Demographic Data for Resource Planning
Willasch, A.
Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC
Willert, J. R.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
Willert, J. R.
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
William, B. M.
Impact of Bone Marrow Neuropathy On the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Williams, K. M.
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Oral Abstracts - Session E - GVH/GVL
Williams, S. N.
Adherence to the Outpatient Oral Medication Regime in Adolescent HSCT Recipients
Wills-Bagnato, P.
Improvement in Early Recognition of Deteriorating Pediatric Bone Marrow Transplant Patients
Willumsen, S.
Can Intravesical Instillation of Recombinant Activated Factor VII (rFVIIa) and Aminocaproic Acid (AA) Stop Bleeding in Hemorrhagic Cystitis?
Wilson, C.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Windreich, R.
Phototoxic Dermatoses in Pediatric BMT Patients Receiving Voriconazole
Winestone, L.
High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease
Wingard, J. R.
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Continuous Infusion Cyclophosphamide and Low Dose Total Body Irradiation (CICy/ldTBI) As a Conditioning Regimen for Tandem Autologous Transplant in Multiple Myeloma
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Winters, E.
Palliative Care Intergration Into an Acute Leukemia and Bone Marrow Transplant Program
Wirk, B.
Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Relapsed After Initial Autologous Hematopoietic Cell Transplantation
Wischmeier, J.
Findings From BONE Marrow Biopsy Pathology Show Plasma CELL Disorders Have Smaller CORE Lengths; Mastocytosis, Myeloproliferative Disorder, and Chronic Lymphocytic Leukemia Have Higher Hemodilution Rates
Wishnew, MD, J.
Why Do Umbilical Cord Blood Units Fail to Qualify for Public Banking?
Wittwer, S.
Significance of Rh Mismatch in Allogeneic Hematopoietic Progenitor Cell Transplants
Witzig, T. E.
Salvage Autologous Stem Cell Transplantation for Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience
Woessmann, W.
Recurrent/Refractory ALCL in Children and Adolescents: Autologous, Allogeneic or No Stem Cell Transplantation?
Wolf, J. L.
Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
Wolf, R.
Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
Wolff, D.
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Wolownik, K.
Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic GVH in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
Won, J. H.
The Effect of Sirolimus Based Regimen On Immune Reconstitution After Allogeneic Stem Cell Transplantation
Wong, I.
A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)
Wong, L.
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Wood, K.
Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Wood, W. A.
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease
Woods, G.
Utilization and Outcome of Bone Marrow Transplantation in Children with Sickle Cell Disease: A Pediatric Health Information System Database Analysis
Woolfrey, A.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Wooten, J.
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Workman, J.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers
Wright, F. A.
Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant
Upfront Calcineurin Inhibitor Dose Reduction of 40% in Pediatric Haematopoietic Stem Cell Transplant Does Not Result in Increased Graft Versus Host Disease in Patients Receiving Voriconazole Maintenance Therapy
Wright, P.
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Wu, D.
Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)
Wu, D.
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Wu, J.
B Cell Engraftment in SCID Patients After Stem Cell Transplantation
Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Wu, J.
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Wu, M.
Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
Wu, N.
Survival After Second Allogeneic Transplant Is Improved in Recipients by Using the Original Donor
Wullfraat, N.
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Wundes, A.
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Wynn, R.
High Engraftment Rates Following Second Allogeneic Transplants for Graft Failure Result in Good Outcomes, On Behalf of the BSBMT

X

Xia, C.
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Xiang, Q.
The Natural History of Children with Severe Combined Immunodeficiency Disease - the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Xiao, K.
Trends in the Incidence and Spectrum of Organisms Responsible for Bacteremia after Allogeneic Stem Cell Transplantation Using Two Different Prophylactic Strategies: A 12-Year Experience at Memorial Sloan-Kettering Cancer Center
Incidence and Kinetics of CMV Infection After T-Cell Depleted and Unmodified Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience At Memorial Sloan-Kettering Cancer Center
Xie, H.
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Xie, S.
Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation
Xu, L. P.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Cytomegalovirus Viremia Is a Risk Factor for Late-Onset Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia

Y

Yabe, H.
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Yahng, S. A.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Yahr, A.
Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin
Yakoub-Agha, I.
Are Outcomes after Myeloablative Conditioning Regimen in Double Cord Blood Transplantation Better than Single UCBT for Adults with Acute Leukemia in Remission?
Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with ACUTE Lymphoblastic Leukemia
Yakouben, K.
Allogeneic Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in France: A Retrospective Study of Société Française De Greffe De Moelle Et De Thérapie Cellulaire
Conditioning Therapy by TBI and Etoposid Causing High Rate of Acute Kidney Injury in ALL Allogenetic Stem Cell Transplantation in Children
Inonilomab for Children with Steroid-Refractory Acute Graft-Versus-Host Disease : A Nationale Multicenter Phase II Retrospective Analysis
Yamamoto, G.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Yamamoto, H.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Yamamoto, R.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Yamane, A.
Safety of Coadministaraion of Teicoplanin and Tacrolimus After Allogeneic Hematopoietic Stem Cell Transplantation
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG
Yang, A.
Promotion of Wound Healing by Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs) in a Murine Wound Healing Model and Analysis On Their Bio-Distribution by in Vivo Bioluminescent Imaging (BLI)
Yang, M.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Yang, X.
In Vivo Generation of Thymus-Independent T Cells in a Tissue-Engineered T Cell Development Supporting Microenvironment
Yanik, G.
Competitive TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Impact of Dose Intensification of FluBu2 to FluBu4 On Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission
A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates That Unrelated Donor Transplants Are As Efficacious As Related Donor, with Favorable Outcomes for Intermediate Risk Disease
Phase 2 Study of Allogeneic Hematopoietic Cell Transplant (HCT) Following Intermediate-Intensity Fludarabine and Busulfan x 4 (FluBu4) Conditioning for High-Risk or Advanced Multiple Myeloma
The Use of Early Spirometric Changes and IGF-1 Levels for the Detection of Patients At Risk for BOS
Pulmonary Complications Following Allogeneic Transplantation
Reducing Transplant-Related Complications
Yankee, T.
An Immunological Assessment of Cytokine Profile of CD4+ Cells in Patients with Chronic Graft Vs Host Disease (cgvhd) Undergoing Extracorporal Photopheresis (ECP)
Yannaki, E.
Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results
Yano, T.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Yates, A.
Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation
Yazigi, N.
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Following Liver Transplantation in Children with Immunodeficiencies
Yeager, A. M.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Yeap, B.
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Yeh, A. C.
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Yeh, R. F.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Yellin, M.
A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers
Yerushalmi, R.
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients with Chemo-Sensitive Disease and with Treosulfan-Based Conditioning
Yi, J. C.
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Yilmaz, M.
Linezolid Use Early After Stem Cell Transplant - A Cautionary Tale
Yin, F.
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Yokoyama, A.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Yolin Raley, D.
Reducing Inappropriate Testing Following NCCN and IDSA Guidelines in Autologous Stem Cell Transplant (SCT) Patients
A Retrospective Review Comparing Outcomes of Patients Receiving Reinduction Therapy On House Staff and PA Services
Advanced Practice Professionals Focus - Systems Capacity Initiative
Q&A
Discussing the NMDP-ASBMT APP Collaboration - Advancing the APP BMT Profession
Yoneda, M.
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming Is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
Yonemoto, K.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Yoneyama, A.
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Yoon, C.
A Comprehensive Review of Dfci's Adult HSCT Data
Yoon, J. H.
Transplantation Outcomes of 8/8-Matched Unrelated Donors Compared with Matched Siblings and Autologous Transplantation for Acute Myeloid Leukemia with Intermediate Cytogenetics in First Remission
Yoshida, S.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Yoshihara, S.
From Murine Model to Clinical Trial of Graft-Versus-Gvhd, a Second Transplantation From Another Donor for the Rescue From Refractory Acute Gvhd
Yotnuengnit, P.
Risk Factors for Dry Eye After Hematopoietic Stem Cell Transplantation
Young, J.
BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse
Comparison of GRAFT Content and Efficiency of T CELL Depletion in BONE Marrow and Peripheral Blood STEM CELLS Grafts After Manipulation by Three Negative or Positive CD34+ Selection Strategies
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Young, J. A.
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Young, L. K.
The Family Experience Following Bone Marrow/Blood Cell Transplantation
Young, S.
Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
Yu, L.
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in Children
Yu, L. H.
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Yu, N.
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Yu, X. Z.
Regulatory T CELLS Specific for Minor Histocompatibility Antigens
Yuda, J.
BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Yun, J. Jr.
The Effect of Sirolimus Based Regimen On Immune Reconstitution After Allogeneic Stem Cell Transplantation
Yurch, M.
Five Innovations in BMT Clinical Research Process
Reduce Errors and Past Due Reports Via Monthly Audits Using Crid Numbers

Z

Zabalza, A.
Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
Zabor, E.
The Management of Relapsed AML or MDS Following a T-Cell Depleted Allogeneic Stem Cell Transplant
Zacarias, N.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Zahner, M.
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Zaia, J.
NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients
Zaidman, I.
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
Zak, P.
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Zakaria, M.
Progressive Vs Non-Progressive Onset of Chronic Gvhd After ATG Prophylaxis Is Highly Predictive of Outcome
Zakrzewski, J. L.
In Vivo Generation of Thymus-Independent T Cells in a Tissue-Engineered T Cell Development Supporting Microenvironment
T Cell Immunotherapy Enabled by Imaging-Guided Injections of Lymphoid Organs
Zakrzewski*, J. L.
Inhibition of c-Rel Activity Prevents Graft-Versus-Host Disease without Compromising Tumor Immunity
Zaleuke, M.
Assessing the Impact of "Survivor Updates" On Staff Caring for Bone Marrow Transplant Patients
Zanter, A.
Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
Zavrelova, A.
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Zecca, M.
Treosulfan for Conditioning in Children and Adolescents before Hematopoietic Stem Cell Transplantation
Zeh, C.
Improving Reliability of Immunosuppressant Sampling Techniques
Zehnder, J. L.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory Gvhd
Zelenetz, A. D.
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Zhang, B.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Zhang, C.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Zhang, D.
Delayed Neutrophil Engraftment Associated with Early CD 8 Polyclonal Lymphocyte Recovery Post Autologous Stem Cell Transplant for Multiple Myeloma
Zhang, K.
Impact of Pharmacogenetics and Therapeutic Drug Monitoring on Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Zhang, M. J.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD)
Zhang, Q.
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Zhang, W.
Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
Zhang, X. H.
Incidence of Invasive Fungal Disease After Unmanipulated Haploidentical Stem Cell Transplantation Was Significantly Higher Than That After HLA-Matched Sibling Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
Zhang, X.
Maintenance Hypomethylating Therapy Post Allogeneic Stem Cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous Leukemia or Non Responsive Myelodysplastic Syndrome
Zhao, L. P.
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Zhao, X. Y.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Zhao, X. S.
Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS
Zhao, Y.
Towards the Development of a Closed, Nanofiber-Based Culture System for Clinical Expansion of Cord Blood CD34+ Cells
Zheng, J.
Impaired B Cell Clonotype Diversification After Allogeneic Hematopoietic Cell Transplantation Predicts Graft-Versus-Host Disease
Zheng, J.
Human Herpesvirus-6 (HHV-6) Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplantation (CBT) Recipients Transplanted without ATG
BK Polyoma Virus (BKV) and Hemorrhagic Cystitis (HC) Post Allogenic Stem Cell Transplant (HSCT): A Prospective Study in a Cohort From Different Stem Cell Sources
Association Between Mycophenolic Acid (MPA) Total Serum Trough Levels and Toxicity and Efficacy Outcomes in Cord Blood Transplantation (CBT) Recipients
Zhong, X.
Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT)
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Plerixafor Overcomes the Adverse Effect of Diabetes On Hematopoietic Progenitor Cell Mobilization
Pre-Transplant Consolidation Chemotherapy Does Not Improve Outcomes Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) for Acute Myeloid Leukemia (AML) in CR1
Zhou, D.
Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation
Zhu, H.
A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients
Zhu, X.
Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A Cibmtr Prospective Study
Ziegler, C.
Defining the GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for Primate GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Zimmermann, M.
Allogeneic HSCT From Unrelated and Sibling Donors Are Equal for Children with Acute Lymphoblastic Leukemia
Zoghi, B.
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Zollikofer, C.
Missing KIR-Ligands in Single Mismatched Unrelated Hematopoietic Stem Cell Transplantation
Zubair, A.
Effect of Body Mass Index On the Mobilizing Efficacy of Plerixafor in Patients Undergoing Autologous Stem Cell Collection: A Retrospective Study

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z